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Abstract
Macrophage Mechanosensing of the Tissue Environment
and Signal Integration Through the Cytoskeleton
Matthew Lowell Meizlish
2021
The extracellular matrix (ECM) is an organized assembly of proteins and polysaccharides that is
produced by cells and forms the physical environment in which cells reside. Together, diverse
cell types and their surrounding extracellular matrix form units of organization known as tissues,
which make up organs. The ECM gives rise to the particular architecture and mechanical
properties of each organ. During tissue repair, cells known as myofibroblasts deposit large
quantities of ECM, in order to reconstruct the injured tissue. In normal tissue repair, that
reparative phase is followed by a resolution phase, in which cells such as macrophages degrade
and remodel excess extracellular matrix, returning the tissue to a homeostatic state. In fibrotic
diseases, however, tissue repair persists, leading to the progressive accumulation of dense, stiff
extracellular matrix that prevents normal organ function and leads to organ failure.

Macrophages are immune cells that reside within all tissues and have important nonimmunologic functions, including sensing and regulating features of the tissue environment.
They often act as sensors within a homeostatic circuit, monitoring a variable of interest and
communicating with other cells, known as effectors, that can correct the variable when it
deviates from the desired range. During tissue repair, monocytes from the blood enter the tissue
and differentiate into macrophages, where they play a critical role both in driving fibroblast
ECM production and in resolving tissue repair through ECM degradation. We hypothesized that
i

macrophages act as sensors of the extracellular matrix within tissues, both to maintain ECM
homeostasis under normal conditions and to monitor the progression of tissue repair to ensure an
appropriate transition to resolution and avoid fibrosis.

In the studies presented in this dissertation, using in vitro hydrogel systems to mimic essential
elements of tissue biology, we find that macrophages can sense changes in the extracellular
matrix and that they respond by regulating a specific subset of their gene expression program
involved in tissue repair. This program includes the protein FIZZ1, which drives fibroblast ECM
deposition and, we find, is suppressed by increased ECM, suggesting that macrophages may be
involved in a negative feedback loop to control tissue repair. We determine that macrophages
sense, in particular, the mechanical properties of the extracellular matrix, and that they employ a
novel, integrin-independent mechanosensing mechanism. Macrophage mechanosensing is
mediated by intracellular changes in the dynamics of the actin cytoskeleton, which ultimately
control chromatin availability and binding of the transcription factor C/EBPb to specific genomic
targets. Furthermore, we identify that the macrophage growth factor, macrophage colony
stimulating factor (MCSF), converges on these cytoskeletal dynamics and downstream
regulatory mechanisms to control the same gene expression program. Thus, we find that
macrophages integrate mechanical and biochemical information about the tissue environment
through changes in their actin cytoskeleton, in order to regulate their tissue repair program. In the
final chapters, we present some of the implications of these findings, as well as broader
perspectives on tissue biology, homeostasis, and inflammation.
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Chapter 1: Introduction
Biological vulnerabilities to disease
The studies described in this dissertation began with a pair of simple questions that arose in the
first week of my PhD: 1) Why, in some cases, does tissue repair inappropriately persist, leading
to fibrotic disease? and 2) How does tissue repair normally turn off? These ultimately led to a
series of more fundamental questions and discoveries about the cellular mechanisms by which
macrophages sense the tissue environment. Building from those first questions, though, I want to
begin this dissertation with a broad framework for thinking about human disease, which has
given shape to, and been shaped by, this work.

Human diseases are often described as malfunctions of human biology. However, they are not
random malfunctions: the repetitive occurrence of certain discrete disease entities indicates that
some pathways are especially vulnerable to disease and that they malfunction in particular,
somewhat predictable ways. One very common type of malfunction takes place when we
mobilize a response to a biological challenge but cannot turn off that response.

For instance, infection triggers mobilization of an immune response. If that inflammatory
response cannot be appropriately shut off, it can lead acutely to pathologies like septic shock or
acute respiratory distress syndrome, or chronically to autoinflammatory or autoimmune diseases.
The response to endothelial injury is thrombosis. However, if this process is unrestrained, it can
lead to a systemic, life-threatening cascade of clotting and bleeding known as disseminated
intravascular coagulation.1 The response to the appearance of old or damaged cells within tissues
1

includes cellular proliferation. However, cell proliferation without appropriate brakes leads to
cancer. Finally, the response to tissue injury is tissue repair, including the deposition of
extracellular matrix to rebuild the tissue. However, a failure to shut off the tissue repair process
leads to sustained extracellular matrix deposition and fibrosis.2

Fibrosis, then, represents one example of a common biological theme: The adaptive responses
that organisms mobilize to survive the immediate challenges that we face also represent our
greatest vulnerabilities to disease.

Extracellular Matrix
The extracellular matrix (ECM) is an organized assembly of proteins and polysaccharides that
comprises the architecture of every organ. It is produced by cells and in turn forms the physical
environment in which cells reside. Together, diverse cell types and their surrounding
extracellular matrix form units of organization known as tissues, which make up each organ and
have a unique composition depending on their biological function (discussed in detail in Chapter
6). Extracellular matrix is an essential element of multicellular life. In the earliest multicellular
organisms, its function was to provide structural support and organization for sheets of epithelial
cells that formed a barrier between the external environment and the internal environment of the
organism.3–5 In contemporary organisms, the fundamental role of the ECM remains the structural
organization of cells within the tissue and the provision of particular mechanical properties that
are necessary for the proper function of each organ.
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A typical tissue contains over 100 extracellular matrix components, including fibrillar proteins
like collagens and elastin, glycoproteins like fibronectin and laminins, and proteoglycans (a
subset of glycoproteins characterized by repeating glycosaminoglycan side chains) like those of
the heparan sulfate family.6,7 Each class of extracellular matrix proteins has characteristic
mechanical functions: Fibrillar collagens, for example, lend the tissue tensile strength, the ability
to resist pulling forces; elastin lends the tissue elasticity, the ability to recoil after being
stretched; and proteoglycans sequester water with their negatively charged glycosaminoglycan
side chains, hydrating the tissue and lending it compressive strength, the ability to resist
compressive forces.8,9 But the ECM is not simply a scaffold. ECM components also have
essential signaling functions. Cellular sensing of ECM composition is known to dictate cellular
fates during organ development10 and stem cell differentiation11,12 and to modulate cell
proliferation,13 survival,14 migration,15 and morphology.16 ECM proteins often have several
distinct structural domains, which mediate specific interactions with other extracellular matrix
components, soluble proteins like growth factors, and cellular receptors, allowing for coordinated
intracellular signaling of complex extracellular conditions.7 The mechanical properties and
biochemical signaling of ECM components are intimately connected. For instance, mechanical
tension in the extracellular matrix exposes ‘cryptic binding sites’ on many ECM proteins that are
otherwise masked, thus switching the set of available molecular interactions under distinct
mechanical conditions.17,18 The ECM is at once a structural meshwork and a complex signaling
network whose language is just beginning to be understood.

In order to serve its core structural and mechanical purpose, the extracellular matrix must be
tightly controlled. The repertoire of ECM components and their relative concentrations—which
3

we can call the ECM composition—together with the spatial arrangement of the ECM, give rise
to its mechanical features. The required mechanics of each organ differ dramatically: The lung
must be compliant and elastic to breathe, while the bone must be able to resist large forces in
order to bear the body’s weight, and their extracellular matrices differ accordingly. The
composition and arrangement of the extracellular matrix can also undergo dramatic changes
within a given organ, physiologically during tissue repair and pathologically in the setting of
fibrosis, cancer, and degenerative diseases.9 The state of the extracellular matrix, then, must be
monitored and regulated, in order to maintain the ECM in its appropriate state during normal
(homeostatic) conditions, or in order to alter the state of the ECM in the setting of repair.

Tissue homeostasis
The extracellular matrix is one of several crucial parameters that must be sensed and regulated
within an organism’s tissues. Other variables that must be tightly controlled to allow for normal
organ function include cell number and organization, oxygen availability, and characteristics of
the interstitial fluid, such as volume, pH, and osmolarity.19–21 Control of most of these variables
within the tissue is not well understood, but the concept of homeostasis can be usefully applied.
Homeostatic circuits are set up to maintain a regulated variable at a particular set point (Figure
1.1a). In order to achieve that end, a sensor monitors the value of the regulated variable. In
response to deviations of the variable from the set point, the sensor releases signals that act on an
effector. The effector acts to modify the value of the regulated variable, returning it to the set
point. If we think about temperature homeostasis within a room, variation in room temperature
(regulated variable) is monitored by a thermostat (sensor), which sends signals to a furnace or air
conditioner (effector), which blows hot or cold air to return the room temperature to its set point.
4

These types of homeostatic circuits are well appreciated in biology, predominantly on an
organismal level, at which variables like glucose concentration and blood pressure are regulated,
and on a cellular level, at which variables like metabolite concentrations are regulated.

This homeostatic framework, however, has not been widely applied to the study of tissue
biology. Part of the reason for this may be a conceptual gap (which we try to help address in
Chapter 6), but the study of tissue biology is also limited by experimental systems. Our
biological tools are largely adapted for the study of individual cells (in vitro) and whole
organisms (in vivo). The biology of tissues has been difficult to model in in vitro systems and
difficult to manipulate within in vivo systems.

Macrophages, which reside within all tissues, are most famous for their role in sensing microbes.
However, in recent years, we have begun to appreciate that macrophages are involved in sensing
and regulating a number of other tissue-level variables, like oxygen tension and osmolarity, in
order to support the functions of the tissues in which they reside.21,22 We reasoned that
macrophages are likely to sense the state of the extracellular matrix, as well (Figure 1.1b). It is
well appreciated that macrophages play an essential role in altering the extracellular matrix, both
through soluble signals to fibroblasts (such as TGFb, PDGF, and Wnt family proteins) to
regulate their synthesis of ECM and by directly degrading and remodeling the ECM through the
production of proteases like matrix metalloproteases (MMPs) and cathepsins.23–28 However,
almost nothing is known about how these macrophage functions are regulated, or whether
macrophages are responsive to variations in the extracellular matrix. We hypothesized that
macrophages act as sensors of key parameters of the ECM, such as its composition and stiffness,
5

and respond to variations in the ECM either by signaling to fibroblasts—which serve as effectors
that can deposit ECM components to restore the ECM to the appropriate state—or by acting as
effectors themselves, directly modifying the ECM through the production of proteases (Fig.
1.1b).

6

A)

B)

Figure 1.1. Hypothesized homeostatic circuit for extracellular matrix regulation
(A) In a homeostatic circuit, a regulated variable is maintained at a set point. A sensor monitors the
regulated variable and, in response to deviations, sends a signal to an effector, which acts on the
regulated variable to return it to the set point. (B) We hypothesized that the extracellular matrix within
tissues is regulated by a homeostatic circuit, in which the composition or mechanical properties of the
extracellular matrix (regulated variables) are monitored by macrophages (sensors), which respond to
deviations in the ECM by secreting soluble factors (signals) to fibroblasts (effectors), which can modify the
ECM to restore it to its set point. Alternatively, macrophages could act as both sensors and effectors,
producing proteases that directly degrade the ECM.

7

Tissue repair and fibrosis
The importance of extracellular matrix regulation to human physiology is dramatically illustrated
by the prevalence of fibrotic disease. Fibrosis is the accumulation of scar tissue—dense, stiff
extracellular matrix—that replaces normal, functioning tissue, eventually leading to organ
failure. Fibrotic diseases are ubiquitous and can occur in almost every organ. They include
pulmonary fibrosis, chronic kidney disease, congestive heart failure, and liver cirrhosis. Fibrosis
in all organs has been estimated to account for one third of all natural deaths worldwide, yet its
underlying pathophysiology remains poorly understood, and few effective therapies have been
developed that target the fibrotic process.29

Fundamentally, fibrosis is a disease of persistent tissue repair. After an injury, the organism
normally mounts a sequence of responses: inflammation, repair, and resolution. First, during
inflammation, an influx of neutrophils and macrophages serve to eliminate the source of injury
and clear out dead cells and other debris. Repair follows: Parenchymal cells proliferate, and new
extracellular matrix is laid down, in large part by cells called myofibroblasts, in order to
reconstruct the architecture of the tissue. Importantly, the extracellular matrix is not simply
returned to its original state; it typically becomes more abundant, more aligned, and stiffer during
this phase, and it is characterized by particular extracellular matrix components, like
matricellular proteins, that are absent or infrequent in normal tissue. As a result, a third phase of
the tissue repair process is essential. In resolution, excess extracellular matrix is degraded and
remodeled, and dedicated cells like myofibroblasts are eliminated, in order to return the tissue to
a homeostatic state.2,30,31 In fibrotic diseases, however, resolution does not take place. Instead,
there is sustained repair, and ECM continues to accumulate. The transition from repair to
8

resolution, then, appears to be a key biological vulnerability that is prone to failure, leading to
fibrosis. Yet, the signals that normally shift the tissue from a state of repair to a state of
resolution remain unknown. We can hypothesize that cells within the tissue monitor the repair
process in order to detect that repair is complete and trigger the transition to resolution.

Control of cell function during the tissue repair process likely emerges from a combination of
soluble signals and instruction from the extracellular matrix.32 Numerous secreted proteins have
been consistently implicated in repair and fibrosis, including TGFb,33,34 PDGF proteins,35 Wnt
proteins,36–38 CTGF,39 IL-4,40 and IL-13.41,42 The importance of the extracellular matrix in
shaping cell behavior has also been well described, especially with respect to fibroblasts. In vitro
studies have demonstrated, for instance, that matrix extracted from patients with pulmonary
fibrosis (compared to normal lung matrix) polarizes fibroblasts in culture toward a pro-fibrotic
program.43,44 Studies in mice have shown that pathways in fibroblasts that mediate ECM sensing
are essential for repair and fibrosis.45,46 The cells responsible for modifying the extracellular
matrix must aggregate and interpret both soluble and matrix-derived information about their
environment.

Macrophages in tissue repair
Based on mouse models in the lung,26,47–49 heart,50 liver,27,51 kidney,52 and skin,28,53 macrophages
appear to be essential in each phase of the response to tissue injury. They are well known for
coordinating the inflammatory response; they drive ECM deposition during repair;28,47–50,52,53 and
they degrade and remodel ECM during resolution.26,27,51,54–56 Though tissue-resident
macrophages are present in all tissues under homeostatic conditions, tissue injury stimulates the
9

recruitment of bone-marrow derived monocytes from the blood into tissues, where they
differentiate into macrophages and participate in tissue repair. Accumulating evidence suggests
that it is these new arrivals that play the critical role in regulating repair.

The relative contribution of macrophage populations has been dissected, for instance, in models
of tissue repair in the lung, which harbors multiple populations of tissue-resident macrophages.
Alveolar macrophages are located within the lumen of the alveoli and have critical functions in
microbial defense and surfactant homeostasis. They originate from the fetal liver and, barring
tissue injury, self-renew throughout life with little replenishment from the blood. Interstitial
macrophages are a heterogeneous population (subdivided by some authors) localized within the
interstitial extracellular matrix of the lung. Their ontogeny and functions are poorly
characterized, but they are good candidates to play a role in regulating tissue organization and
ECM homeostasis, given their position along with fibroblasts within the interstitium adjacent to
alveoli.57–62 After injury, these populations undergo dramatic changes, as monocytes from the
blood infiltrate the damaged tissue. In one study, following lung injury by intratracheal
bleomycin, infiltrating monocytes were responsible for both the increase in number and
functional contribution of macrophages to lung repair.49 Once they entered the tissue, these
monocytes could become tissue-resident macrophages, and over months (after repair) many
gradually adopted the phenotype of alveolar macrophages.49,63 Separately, another group
determined that bone marrow-derived macrophages are required for optimal lung regeneration
after pneumonectomy.64 These analyses were focused on distinguishing between infiltrating
monocytes and resident alveolar macrophages and do not rule out a role for tissue-resident
interstitial macrophages (which may also be replenished from the bone marrow).49,65 However,
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these studies clarify that, in the context of repair and regeneration, infiltrating monocytes that
originate from the bone marrow play a central role in regulating tissue growth and ECM
deposition, and they indicate that the use of bone marrow-derived macrophages (BMDM) in
vitro is appropriate for the study of these processes.

The type 2 cytokines IL-4 and IL-13, which signal through the shared IL4Rα, provide key
signals that instruct macrophages to participate in tissue repair. In the pneumonectomy study
described above, donor bone marrow required intact IL4Rα in order to facilitate lung
regeneration.64 In the intratracheal bleomycin model, knocking out both IL-4 and IL-13 almost
completely abolishes collagen deposition.66 After punch biopsy in the skin, IL4Rα signaling in
myeloid cells is required to stimulate secretion of Found in inflammatory zone 1 (FIZZ1, also
known as Resistin-like molecule alpha (RELMa), official gene symbol Retnla), which in turn
induces fibroblast cross-linking of collagen at the telopeptides, allowing for organized collagen
packing within the tissue and effective wound healing.28 FIZZ1 is also dramatically induced in
the lung following bleomycin injury and, like IL-4/IL-13, is required for effective ECM
deposition.66–68 In vitro, IL-4 or IL-13 have traditionally been used to polarize macrophages to an
‘M2’ or ‘alternatively activated’ state. Though this nomenclature does not capture the range of
functional states that macrophages can assume in response to signals within the tissue
environment,22 it is useful as a well-defined polarization state associated with tissue repair. Bone
marrow-derived macrophage stimulation with IL-4 or IL-13 in vitro induces a well-established
set of genes, including Fizz1, Ym1, Arg1, and Mrc1, that also serve as markers of repairassociated macrophages in vivo. In an in vivo setting, other stimuli can almost certainly stimulate
expression of these genes, which can be co-regulated or induced independently of one another.69
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However, given the established role of IL-4/IL-13 in many models of tissue repair and the ability
of these signals to induce a gene expression program in macrophages that is clearly involved in
tissue repair, these proteins serve as a useful tool for the ex vivo study of elements of macrophage
biology involved in tissue repair.

ECM receptors and mechanosensing
Transmembrane extracellular matrix receptors occupy the interface between cells and the
extracellular matrix. The largest known family of ECM receptors is the integrin family, whose
development predates the origin of multicellular animals. Though integrins are most famous for
their functions in cellular adhesion and migration, the earliest known organisms with integrin
receptors also had the requisite cytoplasmic machinery for downstream signaling, suggesting that
integrins had a primordial function in reporting on the state of the extracellular environment.70
Integrins have expanded dramatically and diversified their substrate specificity in metazoans,
where they interact with the complex extracellular matrix of multicellular tissues. The integrin
family in mammals is made up of 18 different a subunits and 8 different b subunits, which pair
to form 24 known heterodimers that are expressed on the cell surface and that have distinct sets
of ECM ligands.71 The evolutionary and developmental importance of these interactions is
evidenced by a triad of lethal mutations in mice: Loss-of-function mutations in fibronectin, a
major ECM glycoprotein;72 a5 integrin, a fibronectin receptor (when paired with b1 integrin);73
or focal adhesion kinase (FAK), a kinase that signals downstream of integrin receptors,74 all
cause embryonic lethality.75
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ECM receptors not only have molecular specificity; many also have the capacity to sense
mechanical characteristics of the extracellular matrix. The ability of cells to convert mechanical
stimuli into intracellular biochemical signals is called ‘mechanosensing’ or
‘mechanotransduction’. In fibroblasts, integrins play a key role as mechanosensors. They are
coupled intracellularly to large protein complexes called focal adhesions, through which they
connect the extracellular matrix to the intracellular cytoskeleton. This allows for a bidirectional
mechanical relationship between the extracellular matrix and the cell that is essential for
mechanotransduction.76,77 For example, for a5b1 integrin on fibroblasts to sense the stiffness of
a fibronectin substrate, non-muscle myosin II inside the cell must generate force, pulling on the
actin cytoskeleton, which is linked via scaffold proteins to the intracellular portion of the integrin
receptor. That intracellular force causes a5b1 integrin to pull on its extracellular substrate,
fibronectin. If the extracellular matrix is stiff, it exerts tension on the transmembrane a5b1
integrin receptor that switches the receptor from a ‘relaxed’ state, in which it binds the canonical
RGD motif of fibronectin, to a ‘tensioned’ state in which it also binds a ‘synergy site’ in
fibronectin. This interaction allows fibronectin to signal through a5b1 integrin and stimulate
intracellular phosphorylation of FAK.18 The extracellular mechanical state of the matrix is thus
translated to an intracellular biochemical signaling pathway, allowing for downstream changes in
cellular development and behavior.

Transcriptional coactivators Yes-associated protein (YAP) and WW-domain-containing
transcription regulator 1 (WWTR1, or TAZ) have also been identified as key sensors (or, perhaps
more accurately, transducers or mediators) of extracellular matrix stiffness. YAP and TAZ are
best known for promoting cellular proliferation in epithelial cells by translocating from the
13

cytoplasm to the nucleus when the cell lack contacts with neighboring cells. In this case, the
Hippo pathway regulates YAP and TAZ activity. In cultured mesenchymal cells and many
epithelial cells, however, YAP and TAZ are even more potently activated by a stiff substrate, in
a Hippo-independent fashion.78 Lineage fate decisions in mesenchymal stem cells can be
directed by substrate stiffness alone,11 and YAP and TAZ are required for those responses.78 Like
integrin-mediated mechanosensing, YAP/TAZ-mediated mechanotransduction is dependent on
tension in the cytoskeleton exerted by nonmuscle myosin II activity.78 The literature on YAP and
TAZ as mechanosensors has expanded dramatically in the last decade. Yet, interestingly, the
upstream events regulating their activation and translocation to the nucleus remain poorly
defined. In some models, integrins are required for YAP activation, but it is not clear whether
there is a linear signaling pathway from integrins to YAP, or whether integrins are simply
required because they are necessary for cellular adhesion to the extracellular matrix, allowing for
cell spreading. Indeed, in these and other studies, cell morphology and actin dynamics control
YAP activity.12,79

These findings suggest that YAP activity, in the context of mechanosensing, may be controlled
directly by the state of the cytoskeleton. The best-defined example of this type of mechanism is
the transcriptional coactivator myocardin-related transcription factor A (MRTF-A, or MRTF).
MRTF binds to G-actin monomers, which sequester it in the cytoplasm. When G-actin
polymerizes to F-actin, MRTF is released, allowing it to translocate to the nucleus and activate
serum response factor (SRF).80 Interestingly, this mechanism was defined not in the context of
mechanosensing, but rather in investigating the response of fibroblasts to soluble factors in
serum, which, surprisingly, depends upon these mechanical changes in the cytoskeleton.81–83
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Later, it was discovered that MRTF also acts as a mechanosensitive factor in myofibroblasts,
presumably through the same logic: stiff substrates cause increased cell spreading and actin
polymerization, releasing MRTF to the nucleus.45 Thus, in this case, cytoskeletal dynamics act as
an integrator of soluble biochemical signals (serum) and mechanical signals (stiffness) from the
environment, which are ultimately translated to changes in gene expression through the activity
of MRTF. YAP activation, which integrates environmental information about both ECM
mechanics and cell-cell contacts in a cytoskeleton-dependent manner, may follow a similar logic.
Interestingly, at least one report suggests that YAP activity may be regulated by MRTF itself.84

Studies on the functional effects of mechanosensing in fibroblasts consistently identify a positive
feedback loop that is mediated at least in part through YAP, TAZ, and MRTF: Fibroblast sensing
of stiff extracellular matrix causes cellular activation, differentiation to myofibroblasts, and
increased deposition of ECM and mechanical contraction of the matrix. Thus, fibroblast sensing
of increased ECM stiffness causes further stiffening of the ECM.45,85,86 This sort of positive
feedback loop might be required for the accumulation of extracellular matrix during tissue repair,
but its persistence would be expected to give rise to the dense, stiff extracellular matrix observed
in fibrotic disease. Authors of these studies suggest that this may be an important mechanism
underlying the development of fibrosis. This may well be true, but it obscures the important
point that, normally, tissue repair does not lead to fibrosis. Part of the biological picture is
missing here. The identification of this fibroblast-driven positive feedback loop with respect to
ECM stiffness suggests the existence of a related negative feedback mechanism that, in response
to increased ECM stiffness, serves to limit fibroblast activation and transition from repair to
resolution. No such mechanism has been described.
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Though research on extracellular matrix mechanosensing has focused on mesenchymal cells like
fibroblasts, there is also intriguing evidence that macrophages may sense their mechanical
environment and mount important functional responses. By forcing macrophages to adopt an
elongated morphology through culture on micropatterned fibronectin substrates, partial induction
of an M2-like polarization state can be observed.87 This study suggests that macrophages, too,
have the capacity for mechanosensing that can influence cell behavior. It remains to be learned
whether macrophages sense properties of the extracellular matrix, how these signals are
interpreted and relayed, and how that might influence macrophage polarization and function.

Hydrogels for ECM mimicry
As in many of the studies described above, engineered biomaterials have been used in recent
years to mimic features of the extracellular matrix in vitro and, by systematically varying those
features, gain unique insights into the biology of cellular interactions with the ECM. There is a
rich array of biomimetic (biology-mimicking) materials that can be applied to fundamental
questions in biology. Among the most useful tools are hydrogels, which are polymer networks
that swell with water, creating a material with mechanical properties that are similar to those of
mammalian tissues. Perhaps the most important difference between hydrogels and typical cell
culture systems (like tissue culture plastic) is that the mechanical properties of hydrogels can be
controlled. Tuning the gel’s stiffness, in particular, can have far-reaching effects on cellular
behavior.11 The optimal hydrogel system for cell culture experiments depends on the
experimental questions being asked.
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Hydrogels can be two-dimensional (2D) or three-dimensional (3D) culture systems. Many of the
seminal studies on the impact of substrate stiffness on stem cell differentiation were performed in
2D systems, with cells plated on top of ECM-coated gels.11,78,88 Many assays, like imaging, are
simpler and more reliable with a 2D hydrogel.88 However, 3D culture systems, in which cells are
encapsulated within the hydrogel, have the advantage of recapitulating the in vivo phenomenon
of cell-ECM contact on all sides. This may be particularly important in the study of cells like
macrophages and fibroblasts that often reside in the interstitium, surrounded by extracellular
matrix, compared to epithelial or endothelial cells that typically form a monolayer bordering
basement membrane ECM only on one side. The 3D environment captures regulatory dynamics
between cell and ECM that are lost in two dimensions. For instance, Tang and colleagues
demonstrated that differentiation of murine skeletal stem cells to osteoblasts within a 3D
collagen gel depends on stem cell expression of MMP14, a collagen protease, whereas there was
no such requirement on a 2D collagen substrate. Compellingly, the 3D defect phenocopied an in
vivo defect in osteogenesis.12

Hydrogels can be composed of natural or synthetic materials. Hydrogels composed of type I
collagen are an attractive natural option because collagens are the most abundant ECM protein in
mammalian tissues.89 Collagen gels provide a well-defined tissue environment that mimics
important features of in vivo tissues but that lacks the complex interactions between many ECM
components that are present in those tissues. In vitro, collagen self assembles into a solid gel
when warmed and brought to a neutral pH. Cells can be encapsulated in a 3D collagen
environment by mixing them with the liquid collagen substrate prior to gelation. The mechanical
properties of the gel differ depending on the concentration of collagen that is used, and cells are
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able to modify collagen gels through both mechanical contraction and protease activity.90–93
Polyacrylamide (PA) and polyethylene glycol (PEG) are popular synthetic options because they
are relatively inert, can be polymerized using a variety of chemical methods, and are highly
modifiable. PA gels are typically used for 2D applications, while PEG gels can be used for the
3D cell culture. PA and PEG alone cannot support cell survival, so they must be modified with
one or more cellular ligands, creating a hybrid natural-synthetic material.88,94 One major
advantage of this hybrid system is that ECM ligand concentration can be decoupled from the
stiffness (or other mechanical properties) of the gel. Whereas in pure collagen gels the stiffness
increases as a function of collagen concentration, in PA-collagen or PEG-collagen gels the
stiffness can be controlled by varying the concentration or molecular weight of PA or PEG,
while the collagen concentration can be varied independently.95,96

Polyacrylamide or polyethylene glycol can be chemically conjugated to whole proteins, like
collagen or fibronectin, or to isolated peptides that are known to mediate binding of ECM
proteins to cellular receptors. The RGD motif, which is found in several ECM proteins including
fibronectin, and the GFOGER motif of collagen are often used.94 These short peptides have the
advantage of isolating specific ligand-receptor interactions, while whole proteins bind multiple
cellular receptors and have the benefit of preserving a wider range of in vivo signaling properties.

Summary and study objectives
The extracellular matrix is a critical feature of all tissues, providing organization, structural
support, and mechanical properties that allow for proper organ function. As a result, the ECM
must be actively regulated by cells to maintain it in the appropriate state, both under homeostatic
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conditions and in the context of tissue repair, which can lead to fibrosis if unchecked. We know
that cells dynamically synthesize and degrade the extracellular matrix, but we do not know what
parameters of the ECM are sensed in order to regulate these functions or what cells are
responsible for sensing the ECM. We hypothesized that macrophages—which sense other
features of the tissue environment and which are essential participants in tissue repair and ECM
modification—act as sensors of the state of the ECM. In order to dissect this biology, we made
use of hydrogel systems that served as simplified tissue environments and allowed for the
manipulation of specific features of the ECM.

In this dissertation, I will explore the biology of ECM sensing and regulation by macrophages, as
well as broader questions regarding cellular sensing and regulation of the tissue environment. In
Chapter 2, I will show that macrophages are able to sense the mechanical properties of the
extracellular matrix and that ECM sensing controls the macrophage gene expression program
involved in tissue repair. In Chapter 3, I will present data indicating that macrophages sense
ECM mechanics in an integrin-independent fashion that is distinct from established mechanisms
of cellular mechanosensing, and that alterations in cytoskeletal dynamics control downstream
changes in gene expression. In Chapter 4, I will discuss how macrophage cytoskeletal dynamics
integrate this mechanical information with biochemical signaling from the growth factor
macrophage colony stimulating factor (MCSF) and how this is ultimately translated to
transcriptional regulation. In Chapter 5, I will discuss some of the conclusions and implications
of this work, as well as the unanswered questions that it raises. Finally, in Chapter 6, I will
present broader perspectives on homeostasis, inflammation, and tissue biology.
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Chapter 2: Macrophages sense the mechanical properties of the extracellular
matrix to regulate their tissue repair program

Introduction
In Chapter 1, I introduced the hypothesis that macrophages sense the state of the extracellular
matrix, in order to maintain ECM homeostasis and regulate tissue repair. In this chapter, we
employ in vitro hydrogel systems to first ask whether macrophages respond to differences in the
extracellular matrix, and then to ask what specific properties of the extracellular matrix are
monitored. We identify a specific transcriptional program involved in tissue repair that is
regulated by extracellular matrix stiffness, and we explore the functional implications of this
transcriptional program for regulation of fibroblast ECM deposition and tissue repair.

Results
Extracellular matrix regulates a specific subset of the IL-4 induced gene expression program in
macrophages
In order to determine whether macrophages sense the extracellular matrix, we needed to set up
an experimental system that retained key features of in vivo tissue environments, in which
specific properties of the extracellular matrix could be manipulated, and in which we could study
cellular responses to these changes. We made use of three-dimensional type I collagen gels,
which met all of these criteria. When kept cold and at an acidic pH, type I collagen remains in a
liquid phase. When it is warmed and brought to a neutral pH, type I collagen self-assembles into
20

a fibrillar collagen gel, resembling collagen architecture within tissues (although, interestingly,
collagen assembly in vivo depends upon other ECM proteins).97 By mixing collagen with
different volumes of water, we are able to manipulate the concentration of collagen in the
hydrogel, ranging from 2 mg/mL (low-collagen gels) to approximately 7 mg/mL (high-collagen
gels) (Figure 2.1a), which also alters the stiffness of the gel (Figure 2.1b) and the pore size of
the fibrillar network (Figure 2.1c-d). We mixed bone marrow-derived macrophages (BMDM)
with the final collagen solution prior to gelation, in order to culture BMDM within a 3D collagen
environment (Fig. 2.1a). To induce the tissue repair program in macrophages, we treated
macrophages with IL-4 (Fig. 2.1a). This allowed us to ask whether macrophages integrate this
soluble signal indicating the context of tissue repair with information about the tissue
environment, in order to determine the appropriate response. We predicted that macrophages
may alter their transcriptional response to IL-4, depending on the state of the extracellular
matrix. We reasoned that, if we saw changes in gene expression in high-collagen compared to
low-collagen gels, macrophages must be able to detect these differences in the extracellular
matrix and relay that information in order to control gene expression.
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Figure 2.1. Three-dimensional collagen hydrogels allow for manipulation of extracellular matrix
properties
(A) Bone marrow-derived macrophages are cultured within 3D collagen gels that vary from low (2 mg/mL)
to high (7 mg/mL) collagen concentration and treated with or without IL-4. (B) Elastic modulus (stiffness)
of collagen gels, measured by rheometry. (C) Scanning electron microscopy (SEM) of low- and highcollagen gels at lower (above) and higher (below) magnification. (D) Quantification of pore size in SEM
images.
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In order to capture the full gene expression program, we performed RNA sequencing (RNAseq)
of macrophages cultured in low- or high-collagen gels, untreated or treated with IL-4. We
performed principal component analysis (PCA) and found that samples segregated along
Principal Component 1 (PC1) based on treatment with or without IL-4 and segregated along
Principal Component 2 (PC2) based on whether they were cultured in low- or high-collagen gels
(Figure 2.2a). Thus, altering the state of the extracellular matrix caused global transcriptional
changes in macrophages.

Next, we investigated specific genes that were regulated by the extracellular matrix. We
identified a cluster of genes that were induced by IL-4, whose expression was increased in lowcollagen compared to high-collagen gels (Figure 2.2b). A group of these genes, including Fizz1,
Rnase2a, Ear2, Ym1, Fn1, and Ccl24 were consistently upregulated in low- compared to highcollagen gels across dozens of experiments, while other genes that are also classically induced by
IL-4, including Arg1 and Mrc1, were consistently unaffected by the state of the extracellular
matrix (Figure 2.2c). Expression of ECM-sensitive genes, represented by Fizz1, showed a dose
response to the concentration of collagen, while ECM-insensitive genes, represented by Arg1,
did not (Figure 2.2d). We confirmed these findings on the protein level by performing flow
cytometry with intracellular protein staining. We found that FIZZ1 protein levels were high in
low-collagen gels and markedly suppressed in high-collagen gels, while ARG1 protein levels
were unaffected (Figure 2.2e).
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Figure 2.2. A specific IL-4-induced gene expression program is regulated by changes in the
extracellular matrix
(A) Principal component analysis of RNAseq data from BMDM in low- or high-collagen gels, with or
without IL-4 stimulation. (B) Depiction of all individual genes measured by RNAseq analysis, showing the
effect of IL-4 (within high-collagen gels, x-axis) and the effect of low- vs. high-collagen gels (with IL-4
stimulation, y-axis) and colored according to the statistical significance of these effects (q-value < 0.2).
Retnla = Fizz1, Chil3 = Ym1. (C) Expression of individual ECM-sensitive and -insensitive genes in the
setting of IL-4 stimulation, measured by qPCR in a representative experiment. (D) Expression of Fizz1
and Arg1 mRNA, measured by qPCR, in a dose response to collagen hydrogel concentration. (E) FIZZ1
and ARG1 protein, detected by flow cytometry with intracellular protein staining and quantified by the
percentage of cells expressing each protein (based on histogram plots).

26

This pattern of mRNA and protein expression, in which some IL-4 induced genes are regulated
by the ECM and others are not, indicates that the observed effect is not simply a result of
increased or decreased IL-4 signaling. To confirm this, we looked by Western blot at IL-4
signaling, which is mediated by STAT6. We found that phosphorylation of STAT6, representing
STAT6 activation, was equivalent or even slightly lower in low- compared to high-collagen gels
(Figure 2.3a-b), while FIZZ1 protein expression was markedly higher in low-collagen gels
(Figure 2.3a, c). These data indicate that enhanced IL-4 signaling is not responsible for
increased expression of the ECM-sensitive subset of genes, like Fizz1, in low-collagen gels.
They suggest, instead, that there are at least two distinct sub-programs induced by IL-4. At least
one of those programs, represented by Fizz1, is sensitive to changes in the tissue environment
and in particular to the extracellular matrix and can be tuned according to those conditions
(Figure 2.3d).
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Figure 2.3. IL-4 signaling through STAT6 is not affected by the extracellular matrix
(A) Western blot showing phospho-STAT6 (pSTAT6) activation 1 hour and 24 hours after IL-4 stimulation
(or untreated, “Untx”) in high- or low-collagen gels. (B) Quantification of the relative intensity of pSTAT6 /
total STAT6, and (C) of FIZZ1 / GAPDH (housekeeping gene) from a separate Western blot experiment
with the same outcome. (D) Extracellular matrix regulates a sub-program of the IL-4 response.

28

Macrophages sense the mechanical properties of the extracellular matrix
Having established that macrophages regulate gene expression in response to changes in the
extracellular matrix, we wanted to determine what properties of the extracellular matrix they
sense. In principle, macrophages could sense the concentration of individual ECM components,
or they could sense the mechanical properties of the ECM. There are several biological rationales
for the latter hypothesis: 1) The mechanical properties of the ECM represent an emergent
property of the assembly of individual ECM components, so measuring ECM mechanics would
be an efficient way to assess the state of the extracellular matrix as a whole; 2) ECM function is
largely determined by its mechanical properties, so ECM mechanics are likely to be actively
regulated; and 3) the stiffness of the ECM changes dramatically during tissue repair, and
increased ECM stiffness is a hallmark of fibrotic disease, so sensing changes in the ECM
stiffness would be a way to detect the progression of tissue repair and monitor for the
development of fibrotic changes.

In collagen gels, the concentration of collagen is directly related to the mechanical properties of
the gel, including its stiffness and pore size (Fig. 2.1). While this reflects the relationship that
exists in vivo, it limits our ability to experimentally dissect the logic of ECM sensing. In order to
decouple ECM concentration from ECM mechanics, we had to use a different experimental
system. In collaboration with Rita Matta and Dr. Catherine Kim in the laboratory of Dr. Anjelica
Gonzalez, we fabricated polyacrylamide (PA) gels conjugated to the major extracellular matrix
protein fibronectin and cultured BMDM on these hydrogels (Figure 2.4a). In this system, the
density of polyacrylamide (PA) crosslinking determines the stiffness of the gels, but PA is inert
and not bound by cells. Cells bind instead to fibronectin on the surface of the PA gels, the
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concentration of which is held constant. This system allowed us to manipulate the stiffness of the
substrate (Figure 2.4b) without changing the concentration of the ECM ligand.

Morphologically, macrophages on high-stiffness polyacrylamide-fibronectin (PA-Fn) gels spread
more than macrophages on low-stiffness PA-Fn gels, when visualized by light microscopy
(Figure 2.4c) or by immunofluorescence after fixation and phalloidin staining of F-actin (Figure
2.4d). When mRNA expression was measured, the same pattern was observed as between lowand high-collagen gels. The ECM-sensitive gene expression program was elevated in
macrophages on low-stiffness PA gels and suppressed in those on high-stiffness gels, while
expression of Arg1 was unaffected by ECM stiffness (Figure 2.4e). These data indicate that
macrophages are capable of sensing ECM stiffness and that changes in ECM stiffness are
sufficient to regulate the ECM-sensitive gene expression program that we have identified. They
provide persuasive evidence that mechanosensing is responsible for the changes in gene
expression that we observe in the 3D collagen gel system. They also raise important questions
about the mechanism by which macrophages sense the mechanical properties of their
environment, which I will explore further in Chapters 3 and 4.
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Figure 2.4. Extracellular matrix stiffness is sufficient to regulate the ECM-sensitive gene
expression program
(A) Bone marrow-derived macrophages were cultured on 2D polyacrylamide (PA) gels of low or high
stiffness conjugated to 0.2 mg/mL fibronectin. (B) Elastic modulus (stiffness) of PA gels. (C) Morphology
of BMDM adhering to low- or high-stiffness PA-Fibronectin (PA-Fn) gels, by light microscopy and (D) by
immunofluorescence with phalloidin staining after fixation. (E) mRNA expression of ECM-sensitive genes
and Arg1 on low- or high-stiffness PA-Fn gels, with or without IL-4 treatment, measured by qPCR.
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FIZZ1 acts on fibroblasts to regulate the extracellular matrix
We have shown that macrophage mechanosensing of the extracellular matrix regulates a subset
of IL-4-induced genes. Fizz1 (Retnla) is one of the genes whose expression is most dramatically
affected by changes in the ECM (Fig. 2.2b), and we confirmed by flow cytometry (Fig. 2.2e) and
Western blot (Fig. 2.3a) that these changes are consistent on the protein level. Many of the genes
induced in macrophages by IL-4 are also expressed by macrophages in vivo in the context of
tissue repair and have therefore been implicated in the repair process. The function of many of
these genes is unclear, however. In contrast, while many questions remain about the biology of
FIZZ1, there is significant evidence that it plays a major role in driving effective tissue repair.

FIZZ1 protein is secreted by macrophages, but its receptor is unknown. Fizz1-knockout mice
have impaired tissue repair in the lungs after bleomycin injury and in the skin after punch
biopsy.28,68 In both contexts, FIZZ1 was shown to activate fibroblasts, inducing expression in
pulmonary fibroblasts of type I collagen and alpha-smooth muscle actin (aSMA, a marker of
myofibroblast differentiation)67 and expression in dermal fibroblasts of the collagen cross-linking
enzyme lysyl hydroxylase 2 (LH2) and aSMA.28 In the study of dermal tissue repair by Knipper
and colleagues, IL-4 signaling in myeloid cells was required for effective wound healing after
punch biopsy. Impaired IL-4 signaling led to a defect in collagen packing that was phenocopied
in Fizz1-knockout mice and rescued by exogenous FIZZ1 and was traced to impaired collagen
crosslinking by fibroblast LH2.28 Thus, FIZZ1, secreted by macrophages, appears to play a key
role in regulating fibroblast function during tissue repair.
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Because the receptor for FIZZ1 and other features of its signaling mechanism are unknown,
further examining its biological effects in vitro has been challenging. Fibroblasts often used for
in vitro studies, like murine embryonic fibroblasts (MEFs), may not have the necessary receptors
to respond to FIZZ1, and it appears likely that recombinant FIZZ1 produced in bacteria may not
have the appropriate post-translational modifications to retain its signaling function. However,
the dramatic regulation of Fizz1 that we observed, together with its still-mysterious biology,
spawned a new project in the laboratory, led by Dr. Naomi Philip, to identify the receptor for
FIZZ1 and better understand its biological functions. By expressing FIZZ1 in mammalian
Expi293 cells and treating 3T3L1 fibroblast cells with conditioned media, we were able to
confirm that FIZZ1 induces expression of Acta2 (aSMA) and Col1a1 (Collagen I) in fibroblasts
(Figure 2.5). Gaining a better understanding of the biology of FIZZ1 is likely to continue to shed
light on the significance of its regulation by extracellular matrix mechanics. The existing body of
literature, however, suggests some important implications, which are discussed below.
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Figure 2.5. FIZZ1 induces aSMA and type I collagen expression in fibroblasts
Conditioned media from Expi293 cells transfected with a control vector or with Fizz1 was transferred onto
3T3L1 fibroblasts for 24 hours, after which cells were harvested and expression of Acta2 (aSMA) and
Col1a1 (Collagen I) mRNA was measured by qPCR.
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Discussion
In this chapter, we showed that macrophages sense the extracellular matrix in order to regulate
their tissue repair program. We determined that ECM stiffness is the relevant property of the
ECM that is monitored by macrophages. We also confirmed that this gene expression program,
characterized by FIZZ1, has functional implications for ECM regulation by controlling gene
expression in fibroblasts.

In vitro, IL-4 induces a global change in macrophage gene expression that is known as a
polarization state. Macrophages polarized by IL-4 or IL-13 are often known as ‘M2’ or
‘alternatively activated’ macrophages, in contrast to ‘M1’ or ‘classically activated’ macrophages
stimulated by LPS and IFNg. This framework does not capture the plasticity of macrophages and
their ability to adopt a wide range of polarization states in response to the functional demands of
their environment.22 However, when used to describe the in vitro states induced by specific
cytokines, and when it is not understood as a full range of possible macrophage states, the
M1/M2 language can be a useful shorthand. It has likely remained attractive to investigators in
part because the genes induced by these cytokines in vitro map onto those identified in biological
models in vivo and allow for translation between in vivo and in vitro contexts. When ‘M2’
macrophages are identified in vivo, however, they often express some but not all of the classic
M2 marker genes. This disconnect is rarely investigated. One way to understand this finding is to
recognize that macrophages respond not only to IL-4 (or another polarizing signal), but also to
other signals in their environment that provide additional information, reporting on functional
demand and tuning the macrophage polarization state to meet those demands.
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Consistent with this model, we find that a subset of IL-4-induced genes is regulated by the
extracellular matrix, while others are insensitive to changes in the ECM. This finding offers an
example of separable programs within the ‘M2’ polarization state, which joins others in the
literature showing that specific IL-4-induced genes are sensitive to lactic acid and apoptotic cells
in the tissue environment.69,98 The ECM-sensitive subprogram may also be sensitive to other
environmental conditions, and in Chapter 4 we identify at least one other variable, growth factor
availability, that converges on this gene expression program. The specificity of this gene
expression program, together with the observation that STAT6 activation is unaffected by the
ECM, also indicates that there must be a distinct mechanism of transcriptional regulation
involved in controlling these sub-programs. This, too, will be further explored in Chapter 4.

In this chapter, we have identified Fizz1 as the hallmark of the mechanosensitive gene
expression program in macrophages, and I have discussed the evidence that FIZZ1 drives
myofibroblast differentiation, collagen synthesis, and collagen crosslinking during tissue repair,
thus promoting ECM deposition and tissue stiffening. Our data indicate that Fizz1 is suppressed
as ECM stiffness increases. This may be an excellent example of the type of homeostatic circuit
(Fig. 1.1) that we predicted would regulate the extracellular matrix. FIZZ1 acts as a signal
between macrophages (the sensor) and fibroblasts (the effector), reporting on the state of the
extracellular matrix to control fibroblast behavior. In soft ECM, macrophages make more FIZZ1
to drive further ECM deposition and stiffening. When the ECM is stiffer, macrophages suppress
FIZZ1 production to reduce fibroblast ECM production. Thus, this system is likely to function as
a negative feedback loop. This may act as a check on the fibroblast-intrinsic positive feedback
loop discussed in Chapter 1.
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We can also see this biology through the lens of tissue repair. Early after injury, the tissue is soft,
which will cause macrophages to make large amounts of Fizz1 and drive fibroblast ECM
deposition. As ECM accumulates during the course of repair, macrophages will sense the
increasing tissue stiffness and suppress Fizz1 expression, reducing fibroblast activation and
helping to transition from repair to resolution. Notably, Ccl24, one of the other hallmarks of the
mechanosensitive gene expression program, has also been shown to promote tissue repair and
fibrosis in multiple organs and, we find, is suppressed by increasing tissue stiffness.99–101 Thus,
macrophage mechanosensing may serve as the kind of check on tissue repair that we sought to
identify in this study, and it is possible that this checkpoint is impaired in the context of fibrosis.
However, these potential conclusions await validation in animal models and patients. While
Chapters 3 and 4 provide insights into the mechanisms of macrophage mechanosensing,
translation of these results in vivo will require a suitable molecular target by which macrophage
mechanosensing can be specifically disrupted.
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Chapter 3: Macrophages sense ECM mechanics through integrin-independent
changes in cytoskeletal dynamics

Introduction
In Chapter 2, we determined that macrophages sense the mechanical properties of the
extracellular matrix in order to regulate their tissue repair program. Mechanosensing of the ECM
is well-studied in cells like fibroblasts and epithelial cells, which are sessile within the tissue.102
Immune cells like macrophages, meanwhile, can migrate rapidly within tissues, and their cellular
mechanobiology and interactions with the ECM differ accordingly.103 Mechanosensing in
immune cells is just beginning to be investigated and may be governed by a distinct logic and set
of biological mechanisms. In this chapter, we investigate the mechanisms of macrophage
mechanosensing within 3D collagen gels. We discover that macrophages in this context sense
ECM mechanics in a novel, integrin-independent fashion, mediated through changes in
cytoskeletal dynamics.

Results
Macrophage mechanosensing is integrin-independent
Our understanding of cellular mechanosensing of the extracellular matrix has expanded
dramatically in the last 15 years. In 2006, Engler and colleagues discovered, using a
polyacrylamide gel system, that differentiation of mesenchymal stem cells (MSCs) could be
controlled simply by tuning the stiffness of their substrate.11 Dramatically, MSCs cultured on
ECM approximating the stiffness of brain differentiated into neurons, while those cultured on
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ECM approximating the stiffness of bone differentiated into osteoblasts. Since then, a paradigm
has developed regarding the mechanism by which cells sense the stiffness of the ECM. Cells use
transmembrane receptors known as integrins to bind to specific components of the extracellular
matrix, such as fibronectin. Integrins are linked intracellularly to the actin cytoskeleton. When
non-muscle myosin II contracts, it pulls on actin, which in turn pulls on the integrin receptor,
which pulls extracellularly on the ECM ligand. The cell thus exerts tension on the extracellular
matrix in order to probe its stiffness.77 In the best worked out example, this tension on a stiff
fibronectin substrate exposes a new binding site in fibronectin, which is bound by the integrin
receptor and in turn causes intracellular signaling by the integrin receptor through focal adhesion
kinase (FAK).18 In most studies, however, this kind of linear signaling pathway is not identified.
This is true, for example, when it comes to the function of YAP and TAZ as mechanosensors—
they mediate mechano-signaling, leading to transcriptional regulation, but they are not cell
surface receptors and are presumably not the upstream sensors of mechanical tension.
Nonetheless, 1) cell adhesion to the extracellular matrix and 2) mechanical tension mediated by
non-muscle myosin II are required for YAP/TAZ function.78 The dominant assumption in the
field has been that these elements—cell adhesion and mechanical tension—are essential for
cellular mechanosensing of the extracellular matrix.77

Much of the biology of ECM mechanosensing has been learned from the study of fibroblasts.
Therefore, before dissecting the mechanism of macrophage mechanosensing, we first determined
whether murine embryonic fibroblasts (MEFs) in our 3D collagen gel system observe the
expected biological rules based on the literature. Indeed, we found that fibroblasts upregulate the
YAP target gene Ctgf and the myofibroblast marker Acta2 (aSMA) in high-collagen compared
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to low-collagen gels. This mechanosensitive gene expression pattern was eliminated when cells
were treated with blebbistatin, the non-muscle myosin II inhibitor (Figure 3.1a), and inhibited
when collagen-binding integrins were blocked with an antibody targeting b1 integrin (Figure
3.1b). Thus, as expected, fibroblast mechanosensing in 3D collagen gels requires both integrinmediated adhesion to the ECM and mechanical tension exerted by non-muscle myosin II.
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Figure 3.1. Fibroblast mechanosensing in 3D collagen gels is integrin- and myosin II-dependent
(A) Murine embryonic fibroblasts (MEFs) were cultured in 3D low- and high-collagen gels and treated with
the indicated doses of the non-muscle myosin II inhibitor blebbistatin, or with the vehicle DMSO at
concentrations equivalent to the lowest (0.02%) and highest (1%) concentrations of blebbistatin. (B)
MEFs in 3D collagen gels were incubated with a b1 integrin blocking antibody, compared to no antibody
or an isotype control antibody.
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One of the first suggestions that this model may not apply to macrophages was that macrophages
do not appear to express any of the established collagen-binding integrins. Integrins are
heterodimers consisting of an a chain and a b chain. The specific pair determines the specificity
of the receptor. The known collagen-binding integrins all include b1 integrin, paired with a1,
a2, a10, or a11 integrin. These a chains form an evolutionarily distinct cluster that appeared in
vertebrates and include an “aI” domain that distinguishes them structurally from the other ECMbinding integrins.71 None of these four a chains are expressed to any appreciable degree either in
bone marrow-derived macrophages (with or without IL-4) based on our RNAseq data (Figure
3.2a) or in tissue-resident macrophages, based on re-analysis of RNAseq data published by
Lavin and colleagues (Figure 3.2b).63
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Figure 3.2. Macrophages show minimal expression of collagen-binding integrins
(A) Normalized expression levels (transcripts per million, TPM) of all integrin alpha and beta chains in
bone marrow-derived macrophages (BMDM), from RNAseq analysis of BMDM cultured in low- or highcollagen gels, with or without IL-4 stimulation. (B) Normalized expression levels of all integrin alpha and
beta chains in various tissue-resident macrophage populations, based on reanalysis of RNAseq data from
Lavin et al (2014).63 Alpha chains of collagen-binding integrins are highlighted in green (a1, Itga1; a2,
Itga2; a10, Itga10; a11, Itga11).
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In contrast to fibroblasts, when we blocked b1 integrin on macrophages, it had no effect on
mechanosensitive gene expression (Figure 3.3a), indicating that the canonical collagen-binding
integrins are not involved in macrophage mechanosensing in a 3D collagen environment.
Blocking b1 integrin also had no apparent effect on macrophage morphology or migration within
the collagen gels. Similarly, there was no effect on mechanosensitive gene expression after
blocking b2 integrin, the b chain for all of the ‘leukocyte integrins’, which are classically
involved in cell-cell interactions with the endothelium but some of which have been reported to
interact with collagen (Figure 3.3b).104–106 To test the involvement of all integrins, we targeted
Talin1, an adapter protein that connects integrins to the cytoskeleton and is thought to be
universally required for integrin activity. We made BMDM from Tln1f/f LysMCre (knockout)
mice, compared to Tln1f/f (wildtype) mice. Tln1f/f LysMCre macrophages showed depletion of
Talin1, but there was no defect in mechanosensing (Figure 3.3c), indicating that macrophage
mechanosensing is integrin-independent.
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Figure 3.3. Macrophage mechanosensing in 3D collagen gels is integrin-independent
(A) mRNA expression in BMDM incubated with a b1 integrin blocking antibody or isotype control antibody.
(B) mRNA expression in BMDM incubated with a b2 integrin blocking antibody or no antibody. (C) mRNA
expression in BMDM from Talin-flox (wildtype, WT) and Talin-flox LysMCre (knockout, KO) mice.
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Based on the canonical model of ECM mechanosensing, this result was very surprising.
However, as we have discussed, this model was developed by studying cells like fibroblasts,
mesenchymal stem cells, epithelial cells, endothelial cells, and smooth muscle cells. All of these
cell types are typically stationary within the tissue and form firm adhesions to the extracellular
matrix. Importantly, when they migrate, these cells also depend upon integrin-based adhesions to
the extracellular matrix, in order to pull themselves forward. In contrast, leukocytes do not
require integrin receptors in order to migrate within a three-dimensional tissue. Instead of
attaching to the ECM and pulling themselves along (‘crawling’), leukocyte migration is driven
by actin protrusion at the leading edge of the cell and does not depend upon adhesion. This
leukocyte mode of migration resembles ‘swimming’ and allows them to infiltrate a diverse range
of tissues, migrate outside of prescribed paths, and achieve much higher speeds than is possible
through the traditional, crawling mode of migration.103,107,108 These biomechanical differences
are plainly visible in the way that fibroblasts deform collagen gels, compared to macrophages.
Fibroblasts cultured within 3D collagen gels physically contract the gels. In contrast,
macrophages do not contract collagen gels because they do not exert pulling forces on the ECM
(Figure 3.4). These differences between fibroblast and macrophage migration, and their general
mode of interaction with the ECM, make sense of our experimental observations: Just as
fibroblast interactions with the surrounding tissue are integrin-dependent and macrophage
interactions are not, fibroblast mechanosensing is integrin-dependent, while macrophage
mechanosensing of the ECM is integrin-independent.
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A)
Macrophages

Fibroblasts

B)

Figure 3.4. Fibroblasts contract collagen gels, while macrophages do not
(A) Photographs of collagen gels within which bone marrow-derived macrophages (top) or murine
embryonic fibroblasts (bottom) have been cultured for 24 hours. (B) Measurements of the diameter of the
collagen gels pictured in (A).
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Macrophage mechanosensing is mediated through changes in cytoskeletal dynamics
Building on this link between migration and ECM sensing, I wondered whether observing
macrophage migration within high- and low-collagen gels may offer further insights into the
mechanism by which macrophages interpret these environments. Live cell imaging revealed that
macrophages in low-collagen gels migrate much more rapidly than macrophages in highcollagen gels (Figure 3.5a). They also show marked differences in morphology: in low-collagen
gels, macrophages were typically round or had short protrusions that rapidly turned over, while
in high-collagen gels they were often dendritic, with numerous long protrusions that were also
dynamic but turned over more slowly (Figure 3.5b-c). Other groups have similarly observed that
macrophages can vary in morphology and migration speed, depending on matrix architecture.91,93
And recent work has shown that dendritic cells and other leukocytes use dynamic membrane
protrusions, like those we visualized, to mechanically sample and navigate 3D collagen gels and
other complex pore networks.109 I hypothesized that these cytoskeletal dynamics, dictated by the
mechanics of the environment, serve as an intracellular measure of the extracellular environment
and ultimately control the observed changes in gene expression.
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Figure 3.5. Macrophage mechanosensing is associated with changes in cytoskeletal dynamics
(A) Quantification of macrophage migration speed and distance from live cell imaging of BMDM for
approximately 20 hours in low- and high-collagen gels. (B) Characteristic confocal images of BMDM in
low- and high-collagen gels, after fixation and staining with phalloidin (red) to visualize F-actin and DAPI
(teal) to visualize the nucleus. (C) Quantification of cell sphericity of all cells captured in low- and highcollagen gels by confocal imaging.
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To test this model, we directly manipulated macrophage cytoskeletal dynamics to determine
whether this would control the mechanosensitive gene expression program. We blocked actin
polymerization using the inhibitor latrunculin A and found that it profoundly suppressed Fizz1
and the rest of the mechanosensitive gene expression program, while it had no effect on Arg1
and Mrc1 (Figure 3.6a). We found a similar but subtler pattern when we used blebbistatin to
block non-muscle myosin II (Figure 3.6b). In macrophages within 3D collagen gels, non-muscle
myosin II likely does not exert tension on the ECM, but it does play a role in regulating actin
dynamics, as evidenced by the highly dendritic morphology of cells treated with blebbistatin.
Finally, we investigated the role of microtubules, which organize the actin cytoskeleton in
macrophages and control leukocyte migration decisions within 3D collagen gels.109,110 Perturbing
microtubule dynamics with nocodazole similarly suppressed the mechanosensitive gene
expression program, while in this case inducing Arg1 and Mrc1 (Figure 3.6c). Thus, within the
broader response to IL-4, the mechanosensitive module of gene expression was specifically
regulated by manipulating the cytoskeleton, independent of the rest of the IL-4 response. Taken
together, these data support a model in which extracellular matrix mechanics act through their
effects on the cytoskeleton to control macrophage gene expression programs and tune
macrophage polarization.
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Figure 3.6. Cytoskeletal dynamics control the mechanosensitive gene expression program in
macrophages
mRNA expression in BMDM treated with (A) the actin polymerization inhibitor latrunculin A, (B) the nonmuscle myosin II inhibitor blebbistatin, and (C) the microtubule inhibitor nocodazole, compared to vehicle
controls. Genes shown are representative members of the IL-4-induced mechanosensitive gene
expression program (Fizz1, Rnase2a) and the IL-4-induced ECM-insensitive gene expression program
(Arg1, Mrc1).
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Discussion
In this chapter, we have dissected the cellular mechanism by which macrophages interpret the
mechanical features of their environment within a 3D collagen gel. We found that macrophages
do not employ the canonical integrin-dependent mode of mechanosensing that has been shown
for many other cell types. Instead, they sense ECM mechanics in an integrin-independent fashion
that is associated with changes in the cytoskeleton. We found that manipulating the cytoskeleton
directly is sufficient to control the mechanosensitive gene expression program, indicating that
these cytoskeletal changes relay the mechanical information that is sensed in the ECM. Thus, the
mechanical properties of the extracellular matrix are translated into changes in the mechanical
properties of the internal cytoskeleton, which must then result in biochemical changes to control
gene expression. The latter point will be explored in Chapter 4.

This raises an important question that we can only speculate about for now and that I hope will
provide the impetus for further studies: How do extracellular changes in ECM mechanics result
in intracellular changes in the cytoskeleton, if this effect is not mediated through receptor-based
adhesion to the ECM? My intuitions regarding the mechanisms of macrophage mechanosensing
have been very substantially influenced by the progress that has been made in understanding the
mechanisms of leukocyte migration. Here, I owe a debt of gratitude in particular to the Sixt
group, whose elegant studies helped me understand both the apparent integrin-independence of
macrophage interactions with the ECM in our system and the actin cytoskeletal dynamics and
mechanical forces involved in leukocyte migration.103,107,109,111,112 After discovering that
leukocytes in 3D environments do not require integrins to migrate,103 the Sixt group went on to
establish, using inert substrates, that leukocytes can migrate without adhering at all to the
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external environment (though non-specific friction forces are likely necessary).113 They proposed
that this migratory mechanism is driven by actin polymerization at the leading edge of the cell
causing deformation of the cell body, rather than the classic model in which the retrograde force
of actin flow is coupled to extracellular adhesion at transmembrane receptors.111

Related work by the Paluch group emphasized the key conceptual point that adhesion-free
migration has the opposite force distribution of adhesion-based migration: in adhesion-free
migration, the net cellular forces point outward, causing the cell membrane to push against the
environment, while in adhesion-based migration, much larger net cellular forces point inward, as
cell-surface receptors pull against the environment.108 Thus, macrophages engaging in integrinindependent migration in a 3D collagen gel may be considered “pushers” while fibroblasts
engaging in adhesive migration would be considered “pullers” (evidenced by their contraction of
the collagen gel).

How might these pushing forces be translated into changes in actin cytoskeletal dynamics? In
2017, in a different line of work, the Sixt group found that actin filaments pushing against
different mechanical loads at the cell membrane organized into distinct configurations. This
process did not require any signaling pathways, instead emerging from the geometry of branched
actin and limited access of capping proteins to the actin filaments near the cell membrane.112
Thus, the actin network has an intrinsic response to extracellular mechanics that does not require
any receptor-mediated binding to extracellular proteins.
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The problem of how cytoskeletal dynamics in leukocytes respond to their physical environment
is not only a question that is important for understanding mechanosensing, but also a
fundamental question in cell migration. In 2019, the Sixt group showed that leukocytes are able
to discriminate between larger and smaller pores, in order to navigate a complex 3D
environment. They argue that, as leukocytes extend actin protrusions into pores to sample their
environment, the bulky nucleus follows and acts as a mechanosensor to detect ECM resistance.
In response, the microtubule organizing center coordinates actin dynamics to redirect the cell
along the path of least resistance.109 This helps to explain the dendritic morphology and slow
migration that we observe in high-collagen gels, compared to the more amoeboid morphology
and faster migration in low-collagen gels. These cytoskeletal dynamics are a direct response to
the mechanical environment: Macrophages in high-collagen gels encounter smaller pores and a
stiffer extracellular matrix and thus greater resistance from their environment, which forces them
to extend membrane protrusions to explore a wider variety of paths. Macrophages in lowcollagen gels navigate a matrix with larger pores and softer ECM and thus encounter less
resistance, allowing them to extend only short protrusions and to migrate more rapidly. How
exactly the cell translates that mechanical resistance into changes in actin dynamics is an
extremely complex mechanobiological question and is an area of active study. What we can
conclude, though, from this body of literature together with our data, is that the mechanical
environment clearly shapes the dynamics of the actin cytoskeleton, and that these dynamics are
not only directly useful for cell migration, but also contain information about the external
environment and can therefore be measured by the cell in order to inform other cellular
functions, such as gene expression.
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Several additional predictions and questions arise from the discussion above. First, whereas
fibroblasts and other cells sense tension forces as they pull on the extracellular matrix, I predict
that macrophages sense compression forces as they migrate and push against the surrounding
extracellular matrix. This is consistent with the idea that macrophages are “pushers” rather than
“pullers”, exerting net outward forces against their environment, and it makes sense that sensing
compressive forces from the environment would not require any specific adhesions to the
extracellular matrix. Second, macrophages may sense these compression forces at the cell
membrane, perhaps causing direct rearrangement of the actin cytoskeleton,112 or at the nucleus,
perhaps leading to microtubule-directed control of the actin cytoskeleton,109 or a combination of
these and other mechanisms. More traditional signaling pathways that regulate actin dynamics,
like the Rho-GTPases,114,115 may also play a role, but we found that chemical inhibitors targeting
these pathways did not specifically modulate the mechanosensitive gene expression program.
Third, we do not know the specific mechanical parameter that is sensed in 3D collagen gels. On
2D polyacrylamide gels, we specifically manipulate the stiffness of the substrate and can say
with some certainty that macrophages are sensing this difference in stiffness. Within a more
complex 3D environment, though, multiple mechanical properties vary together. We have shown
that high-collagen gels are not only stiffer, but also have smaller pore sizes than low-collagen
gels, and we have discussed evidence from the literature that leukocytes can discriminate
between smaller and larger pores.109 As I have indicated, I suspect that the relevant property of
the ECM is the resistance or compressive force that macrophages encounter, and multiple
features of the environment, including stiffness and pore size, may contribute to this net effect.
Importantly, these features are also likely to co-vary in vivo, as increased ECM deposition would
lead to both increased stiffness and reduced pore size.
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Finally, it is important to note that we used a 2D polyacrylamide-fibronectin system (Chapter 2)
to formally demonstrate that the ECM-sensitive gene expression program is in fact a
mechanosensitive gene expression program. Unlike 3D collagen gels, this 2D system is
adhesion-dependent. In fact, we used fibronectin rather than collagen because macrophages do
not adhere to collagen (presumably due to the absence of collagen-binding integrins, as we have
shown), but do adhere to fibronectin. This is consistent with the literature: the same paper that
demonstrates integrin-independent leukocyte migration in 3D environments (in 3D collagen gels
in vitro and within tissues in vivo) also demonstrates that integrins are absolutely required for
migration on 2D substrates in vitro and for transmigration from vasculature into tissues in vivo.
Surprisingly, b1 integrin blockade (which would block the fibronectin receptor a5b1 integrin)
did not impair adhesion or mechanosensing on PA-Fn gels. However, other fibronectin receptors,
such as aVb3, may be involved, and we assume at present that macrophage mechanosensing on
2D PA-Fn gels is integrin-dependent. If that is right, it is very interesting that integrinindependent mechanosensing (likely sensing compressive forces) and integrin-dependent
mechanosensing (likely sensing tension forces) converge on the same gene expression program.
Macrophages showed increased cell spreading on stiff compared to soft PA-Fn gels, and we can
imagine that these cytoskeletal changes may be similar to those that take place in 3D highcollagen compared to low-collagen gels, ultimately communicating the same information
intracellularly and leading to the same events in the regulation of gene expression.
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Chapter 4: The cytoskeleton integrates mechanical and biochemical signals in
the tissue environment to regulate transcription

Introduction
In Chapter 2, we identified that macrophages sense extracellular matrix mechanics to regulate
gene expression, and in Chapter 3, we determined that this mechanosensing was mediated
through changes in the actin cytoskeleton. In this chapter, we show that signaling by macrophage
colony stimulating factor (MCSF), the lineage-restricted growth factor for macrophages, can
cause similar changes in actin dynamics and regulate the same gene expression program. These
cytoskeletal effects are mediated by MCSF signaling through PI3K and GSK3 and are required
for the MCSF effect on the mechanosensitive gene expression program but not other genes. Both
MCSF stimulation and direct perturbation of the cytoskeleton regulate chromatin accessibility
and C/EBPb binding at the Fizz1 but not the Arg1 locus. Thus, we show in this chapter that the
cytoskeleton acts as an integrator of mechanical and biochemical signals to regulate specific
transcriptional targets.

Results
MCSF controls cytoskeletal dynamics to regulate the mechanosensitive gene expression program
MCSF induces macrophage differentiation, proliferation, and survival. To grow bone marrowderived macrophages, we use conditioned media from a fibroblast cell line called L929 that
makes large quantities of MCSF, which induces the differentiation of hematopoietic stem cells
obtained from the bone marrow into mature macrophages. Several years ago, Dr. Scott Pope in
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our lab made the observation that, after macrophage differentiation, removing L929 conditioned
media had significant effects on macrophage gene expression in response to the polarizing
signals LPS and IL-4. Fizz1 was among the genes that was most highly regulated. Since our
initial experiments were performed in L929-conditioned media, we began to perform
experiments to make sure that the phenotype we observed was not a consequence of the relative
availability of MCSF in low- and high-collagen environments. We first confirmed that
macrophage responses to ECM are intact in the absence of L929 conditioned media or other
sources of MCSF (and we then continued to use MCSF-free conditions in most of the
experiments presented throughout Chapters 2 and 3). In these experiments, we also made the
discovery that L929 conditioned media or recombinant MCSF specifically suppressed the same
gene expression program as high-stiffness ECM, including Fizz1, Ym1, Rnase2a, and Ccl24
(Figure 4.1a). In contrast, MCSF either increased or had no significant effect on the expression
of the ECM-insensitive IL-4-induced genes Arg1 and Mrc1 (Figure 4.1b). We confirmed these
findings on the protein level using flow cytometry with intracellular protein staining for FIZZ1
and ARG1 (Figure 4.1c).

MCSF also had dramatic morphologic effects on macrophages. On cell culture dishes, the
addition of MCSF caused macrophages to spread and extend long protrusions of their cell
membranes (Figure 4.1d) Similarly, in live cell imaging in 3D collagen gels, macrophages
treated with MCSF migrated more slowly and became more dendritic, extending long membrane
protrusions, closely resembling the cytoskeletal dynamics in high-collagen compared to lowcollagen gels. Thus, MCSF and high-stiffness ECM appear to converge on similar effects on
both the cytoskeleton and gene expression. To determine whether the effects on gene expression
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are mediated through the effects on the cytoskeleton, we treated macrophages with MCSF under
normal conditions or after inhibiting actin polymerization using latrunculin A. While MCSF
potently suppressed Fizz1 when the cytoskeleton was intact, treatment with latrunculin A
strongly attenuated the effects of MCSF on Fizz1 expression. In contrast, the effects of MCSF on
Arg1 were unaffected by the state of the cytoskeleton (Figure 4.1e). Control of the
mechanosensitive gene expression program by MCSF, then, appears also to be mediated by
MCSF remodeling of the cytoskeleton.
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Figure 4.1. MCSF-induced cytoskeletal remodeling regulates the mechanosensitive gene
expression program
(A) mRNA expression of mechanosensitive genes in BMDM cultured in standard complete RPMI (cRPMI)
media or with the addition of 15% conditioned media from L929 cells, which produce large quantities of
MCSF (+15% L929), or 100 ng/mL recombinant MCSF protein (+100 ng/mL MCSF). (B) mRNA
expression of IL-4-induced ECM-insensitive genes from the same experiment. (C) FIZZ1 and ARG1
protein in BMDM cultured in cRPMI or 15% L929-conditioned media, detected by flow cytometry with
intracellular protein staining and quantified by the percentage of cells expressing each protein (based on
histogram plots). (D) Representative morphology of BMDM on tissue culture plates, cultured in standard
cRPMI media or stimulated with 100 ng/mL recombinant MCSF. (E) mRNA expression (above) of Fizz1
and Arg1 after BMDM stimulation with IL-4, with or without latrunculin A treatment and with or without
MCSF stimulation. Quantification (below) of the relative effect of MCSF on gene expression without
latrunculin A treatment (cytoskeleton intact) and with latrunculin A treatment, which inhibits actin
polymerization.
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Next, we dissected what signaling pathways are responsible for the effects of MCSF on the
macrophage cytoskeleton and downstream gene expression program. The fact that MCSF
induces actin remodeling in macrophages is well established in the literature, and these effects
are thought to be initiated by activation of PI3K by the MCSF receptor CSF1R.116–118 When we
treated macrophages with MCSF-containing media and blocked PI3K signaling using the
inhibitor wortmannin, both the cytoskeletal effects (Figure 4.2a) and the downstream gene
expression effects (Figure 4.2b) of MCSF were attenuated, whereas there was no effect on the
expression of Arg1, which we have found to be cytoskeleton-independent and is presumably
regulated by MCSF by a distinct signaling pathway.

One of the effects of the PI3K signaling pathway is to phosphorylate and thereby inhibit the
kinases GSK3a and GSK3b. When we inhibited these kinases pharmacologically using the
inhibitor SB216763, this recapitulated the morphologic effects of MCSF (Figure 4.2c) and
inhibited Fizz1 without affecting Arg1 expression (Figure 4.2d). These data suggest that MCSF
signaling through a PI3K-GSK3 pathway may be responsible for the cytoskeletal remodeling and
the cytoskeleton-dependent gene expression effects of MCSF.
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Figure 4.2. MCSF signals through a PI3K-GSK3 pathway to regulate cytoskeletal dynamics and
gene expression
(A) Characteristic morphology of BMDM cultured on tissue culture plates in complete RPMI media
(cRPMI), with 30% conditioned media from MCSF-producing L929 cells (+ L929), or with 30% L929conditioned media and the PI3K inhibitor wortmannin (5 uM) (+ L929 + wortmannin). (B) mRNA
expression in BMDM cultured in cRPMI media without stimulation, treated with 100 ng/mL MCSF, or
treated with 100 ng/mL MCSF and 5 uM wortmannin. (C) Characteristic morphology of BMDM on tissue
culture plates in cRPMI media, treated with 100 ng/mL MCSF, or treated with the GSK3 inhibitor
SB216763 (10 uM). (D) mRNA expression in BMDM treated with vehicle control (0.05% DMSO) or the
GSK3 inhibitor SB216763 (10 uM).
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The actin cytoskeleton controls chromatin availability and C/EBPb binding at specific genomic
loci
Having determined that ECM mechanosensing and MCSF signaling converge on actin
remodeling in macrophages in order to regulate a specific gene expression program, we next
asked how these changes in cytoskeletal dynamics are translated to control of gene expression.
To investigate whether actin remodeling in macrophages results in changes in chromatin
accessibility, we performed ATACseq in BMDM treated with and without IL-4 and with or
without latrunculin A, SB216763 (GSK3 inhibitor), and MCSF, all of which control macrophage
cytoskeletal dynamics and suppress expression of Fizz1. We found that IL-4 induced chromatin
opening at the Fizz1 promoter (immediately upstream of the gene, containing the functional
STAT6 binding site)119 and that this chromatin opening was suppressed by latrunculin A, Gsk3
inhibition, and MCSF treatment (Figure 4.3a). In contrast, the Arg1 locus did not show marked
changes in chromatin accessibility, including at the enhancer where STAT6 binding is required
for induction (Figure 4.3b).120,121 These data suggest that actin remodeling controls chromatin
accessibility, in order to regulate gene expression.

To gain insight into the transcription factors that may be involved, we took a global view of the
ATACseq data and asked which transcription factor motifs were enriched in regions of
chromatin that were made significantly less accessible by the cytoskeletal perturbations
(corresponding to the suppressed expression of mechanosensitive genes like Fizz1). In regions of
chromatin suppressed by latrunculin A, SB216763, or MCSF, C/EBP binding sites were among
the most enriched transcription factor binding motifs, in the setting of IL-4 (Figure 4.3c) and
similarly without IL-4 treatment. This pattern was particularly interesting because Fizz1 is
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known to be regulated by C/EBPb, which binds the Fizz1 promoter adjacent to STAT6.119
Several genes in the mechanosensitive gene expression program also have consensus C/EBP
binding sites in their promoters, including Ear2 and Rnase2a. However, Arg1 is also known to be
regulated by C/EBPb, which binds the Arg1 enhancer adjacent to STAT6, similar to its
regulation of Fizz1. If C/EBPb is involved in regulating the transcription of Fizz1 and other
mechanosensitive genes downstream of cytoskeletal control, it was not immediately clear how
this could result in the pattern that we have consistently observed, in which regulation of Fizz1 is
decoupled from that of Arg1.

To test whether C/EBPb activity is regulated by the cytoskeleton, we performed chromatin
immunoprecipitation (ChIP) for C/EBPb without IL-4 stimulation, with IL-4 stimulation, with
IL-4 plus L929-conditioned (MCSF-rich) media, and with IL-4 plus latrunculin A. We found that
IL-4 stimulation potently induced C/EBPb binding to the Fizz1 promoter and that additional
treatment with L929 or latrunculin A completely abrogated that binding. In contrast, C/EBPb
binding to the Arg1 enhancer was present at baseline, increased with IL-4 stimulation, and was
essentially unaffected by the cytoskeletal perturbations (Figure 4.3d). These patterns of C/EBPb
transcription factor activity closely mirrored the gene expression patterns of Fizz1 and Arg1,
suggesting that regulation of C/EBPb is likely to be a key biochemical mechanism by which
changes in cytoskeletal dynamics are translated to control of gene expression.
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Figure 4.3. Cytoskeletal dynamics control chromatin availability and C/EBPb activity in a targeted
fashion
(A-B) Tracks representing the chromatin state of the genomic regions surrounding the Fizz1 (A) and Arg1
(B) genes, based on ATACseq analysis of BMDM treated with or without IL-4 and with vehicle control
(0.025% DMSO), latrunculin A (1 uM), SB216763 (GSK3 inhibitor, 5 uM), or recombinant MCSF (100
ng/mL). (C) Transcription factors motifs (and corresponding p-values) that are most enriched in regions of
open chromatin in IL-4 stimulated BMDM cultured under control conditions compared to BMDM treated
with latrunculin A, SB216763 (GSK3 inhibitor), or MCSF. (D) Binding of the transcription factor C/EBPb to
the Fizz1 promoter and Arg1 enhancer regions of DNA in BMDM cultured in complete RPMI (cRPMI)
media, treated with IL-4, treated with IL-4 and L929-conditioned media, or treated with IL-4 and latrunculin
A (LatA), based on chromatin immunoprecipitation.
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Discussion
In this chapter, we found that stimulation of macrophages with the growth factor MCSF
regulates the same gene expression program as mechanosensing of the ECM. We found that
MCSF induces similar changes in the cytoskeleton as those observed in response to highstiffness ECM and that these changes are required for MCSF control of the mechanosensitive
gene expression program. We identified a PI3K-GSK3 mediated signaling pathway that is
required for both the cytoskeletal and downstream gene expression effects of MCSF. Finally, we
interrogated the mechanisms by which actin dynamics may be translated to changes in gene
expression. We determined that alteration of the actin cytoskeleton controls chromatin
accessibility and binding of the transcription factor C/EBPb at the genomic locus for regulation
of Fizz1 but not Arg1, which could explain why a specific module of the IL-4 response is
regulated by mechanosensing and growth factor signaling, while other elements of the IL-4
response are unaffected.

Among the most interesting implications of the findings presented in this chapter is that MCSF
must remodel the actin cytoskeleton in order to regulate some of its genetic targets. In the case of
mechanosensing, it is somewhat intuitive that extracellular mechanical information (contained in
the ECM) would be translated to intracellular mechanical information (contained in the
cytoskeleton), which would ultimately be translated to a biochemical signal to regulate gene
expression. In the case of growth factor signaling, however, it is not intuitive why the biological
system would be structured in this way: Extracellular biochemical information (in the form of
MCSF) is converted to intracellular mechanical information (in the effects on the cytoskeleton),
which ultimately is translated back to biochemical information to control gene expression. The
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intermediate mechanical step seems to be an unnecessary complication in the transmission of
biochemical information. Yet, this model appears elsewhere in biology. The best example is the
story of serum response factor, mentioned in Chapter 1. It was known that fetal calf serum
activates a transcriptional program in fibroblasts (and smooth, skeletal, and cardiac muscle cells)
controlled by the transcription factor serum response factor (SRF), but the link between the
growth factors present in the serum and the activation of SRF in the nucleus was unknown. The
key to this puzzle was that treatment of fibroblasts with serum also causes morphologic changes
in the cells, indicating remodeling of the cytoskeleton. The Treisman group discovered initially
that these changes in actin dynamics are required for SRF activation of many of its
transcriptional targets.81 They later determined the mechanistic basis by which cytoskeletal
changes are translated to control of gene expression: The transcriptional co-factor MRTF is
sequestered in the cytoplasm by G-actin monomers and released to the nucleus when these
monomers polymerize into F-actin.82 A greater degree of complexity in these regulatory
mechanisms, including a role for nuclear actin, is now appreciated,80 but the conceptual
implications are the same: The growth factors present in serum signal not through a linear
biochemical mechanism, but rather by remodeling the cell’s cytoskeleton, the state of which
regulates the biochemical activity of a transcription factor. This is highly reminiscent of our
discovery presented in this chapter, that a subset of MCSF’s gene expression effects are
mediated through its remodeling of the macrophage cytoskeleton, which is likely translated to
transcriptional regulation in part through the activity of the transcription factor C/EBPb.

While the advantages of this signaling architecture are not immediately obvious, we can
speculate: One possibility is that the cytoskeleton acts as a critical signal integrator. I will
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explore this theme—that cellular morphology may be a key indicator and regulator of the cellular
state—more in the following chapter. For now, I will note that MCSF acting through a
cytoskeleton-dependent mechanism allows it to converge on the same transcriptional program as
that regulated by ECM stiffness. Thus, distinct types of information are effectively integrated in
their effects on the cytoskeleton. The same is true for the MRTF-SRF mechanism in fibroblasts:
ECM stiffness, through its effects on the fibroblast cytoskeleton, converges on the same gene
expression program as serum stimulation.45,122

However, the cytoskeleton-dependent targets of MCSF signaling, like Fizz1, are separable from
other targets of MCSF regulation, such as Arg1, which are likely regulated by a more traditional
biochemical signaling pathway and are, accordingly, also unaffected by ECM stiffness. The
separation between these modules may have to do with the functional roles of the genetic targets.
This suggests a second, related reason that cells may use a cytoskeleton-dependent mechanism of
transcriptional regulation: target genes may be involved in cellular processes that are consistently
associated with morphologic change, such as migration, adhesion, and interaction with other
cells.

A third potential rationale for biochemical signals to remodel the cytoskeleton in order to control
gene expression is that these cytoskeletal dynamics allow for a distinct mechanism of
transcriptional regulation. For instance, the actin cytoskeleton may exert tension on the nuclear
membrane, which could mechanically alter the availability of local chromatin. In order to test a
version of this idea, we performed experiments with BMDM deficient in Sun2, a member of the
LINC complex that connects the nuclear membrane to the actin cytoskeleton.123,124 Interestingly,
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we did see a partial attenuation of the effects of MCSF on Fizz1 and especially Rnase2a
expression, but we did not further pursue this hypothesis because Sun2 deficiency had a
negligible effect on expression of these genes in response to ECM mechanosensing. A related
idea is that nuclear actin may play a key role in chromatin remodeling and transcriptional
regulation.125–127 We have taken initial steps to collaborate with Dr. Shangqin Guo’s group to test
a version of this hypothesis by expressing actin with a nuclear localization signal (NLS) (or actin
with a NLS that is constitutively in the G-actin or F-actin form) and testing whether this alters
regulation of the mechanosensitive gene expression program, chromatin availability, and activity
of C/EBPb. In support of this general model, in which the cytoskeleton is involved in chromatin
remodeling in macrophages, we observed a global increase in chromatin availability by
ATACseq when actin polymerization was inhibited with latrunculin A.

In this chapter, we determined that binding of the transcription factor C/EBPb to the regulatory
region of Fizz1 but not Arg1 is regulated by the actin cytoskeleton. I originally identified C/EBP
family members as interesting candidates because of a study published by Stutz and colleagues
in 2003 identifying a C/EBP binding site, adjacent to the STAT6 binding site in the Fizz1
promoter, that is required for full induction of Fizz1 by IL-4 or IL-13.119 There is also some
precedent for C/EBP family members, and C/EBPb in particular, to act as mechanosensitive
transcription factors in other contexts, for instance in osteoblasts in response to shear stress and
in aortic smooth muscle cells in response to cyclic stretch.128,129 C/EBP binding motifs are also
present in the promoters of several of the mechanosensitive genes in macrophages. The fact that
Arg1 expression, which we find to be regulated independently of Fizz1, was also known to be
regulated by C/EBPb did not initially fit with this hypothesis, however. This puzzle was
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satisfyingly resolved by the results of the ChIP experiment, which showed that C/EBPb indeed
binds both the Fizz1 promoter and the Arg1 enhancer, but its binding at the Fizz1 promoter is
dramatically regulated by the actin cytoskeleton, which is not the case at the Arg1 enhancer.
Thus, what distinguishes regulation of Fizz1 from that of Arg1 may not be the transcription
factor that is responsible, but rather an upstream mechanism that controls that transcription
factor’s activity in a site-specific manner.

What is responsible, then, for the differential control of C/EBPb activity at the Fizz1 compared
to the Arg1 locus? Our data show that the actin cytoskeleton regulates C/EBPb binding to the
Fizz1 promoter, but it is not clear whether this effect is direct or indirect or what type of
mechanism is involved. One possibility is that actin dynamics regulate the availability of
chromatin for transcription factor binding, perhaps through mechanical effects on the nucleus or
through the effects of nuclear actin, as discussed above. Our ATACseq data indicate that
chromatin openness at the Fizz1 (but not the Arg1) locus is regulated by actin dynamics,
providing general support for a model in which cytoskeletal dynamics directly control chromatin
remodeling, which in turn opens up Fizz1 and other mechanosensitive loci for C/EBPb and other
transcription factor binding. However, these changes in chromatin openness could also be a
secondary effect of C/EBPb binding, which could remodel the local chromatin landscape to
allow for active transcription.

It is entirely possible that the cytoskeleton regulates C/EBPb activity directly, by a mechanism
that remains to be defined. We investigated the possibility that C/EBPb localization is regulated
by actin dynamics, but we did not observe a clear signal of nuclear translocation in response to
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MCSF or latrunculin A, by immunofluorescence or cell fractionation. Under all conditions,
C/EBPb was predominantly nuclear. A more likely scenario is that actin dynamics regulate
C/EBPb activity within the nucleus.

Another alternative is that GSK3 acts as the direct regulator of C/EBPb activity. We have
observed that GSK3 inhibition causes cytoskeletal remodeling, and we have suggested that these
cytoskeletal changes mediate the effect of this pathway on gene expression (in part because of
data indicating that the full effect of GSK3 inhibition requires an intact cytoskeleton). It is also
possible, however, that MCSF- and ECM-induced cytoskeletal dynamics instead control GSK3
activity. I initially became interested in GSK3b because of evidence in the literature that it can
act on C/EBPb to control its DNA-binding activity. When 3T3-L1 preadipocytes are induced to
differentiate into adipocytes, GSK3b undergoes a delayed translocation from the cytoplasm to
the nucleus, where it phosphorylates C/EBPb to activate its DNA-binding activity, allowing it to
drive the adipocyte differentiation program.130,131 Intriguingly, expression of Fizz1 is also
induced in adipocytes upon differentiation. Furthermore, GSK3b only phosphorylates C/EBPb
once it has been “primed” by phosphorylation at another site. That initial phosphorylation event,
which is performed by MAPK, also occurs in the late stages of monocyte differentiation to
macrophages and appears to be critical for macrophage identity.132 MCSF is the growth factor
that drives monocyte differentiation into macrophages, and it activates MAPK, so it is likely that
MCSF (perhaps cytoskeleton-independent) signaling is responsible for the initial
phosphorylation of C/EBPb by MAPK, which induces C/EBPb activation of the genes that are
responsible for macrophage identity, as well as its basal binding activity to the Arg1 locus, which
we observe in our ChIP data. In contrast, DNA binding to other targets, such as Fizz1, may
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require the secondary phosphorylation event by Gsk3b. Unfortunately, we were not able test this
hypothesis directly because, to our knowledge, there are no published antibodies against the
GSK3b-mediated phosphorylation site on C/EBPb, and we did not have the available tools, such
as mass spectrometry and mutated versions of C/EBPb, to further dissect this biology. We were
not able to detect clear evidence that cytoskeletal perturbations control either GSK3b
translocation from the cytoplasm to the nucleus or inhibition of GSK3b through phosphorylation,
though these events are not strictly necessary for this model. Thus, while our experimental
evidence to date best supports a model in which MCSF-induced activation of GSK3b acts
upstream of cytoskeletal remodeling, there is intriguing circumstantial evidence from the
literature that suggests an alternative model, in which cytoskeletal remodeling controls GSK3b
activity, which in turn phosphorylates C/EBPb and controls site-specific DNA-binding to targets
in the mechanosensitive gene expression program.

Finally, I must note that the data we have presented shows cytoskeletal regulation of C/EBPb
binding to the Fizz1 promoter, independent of its binding to the Arg1 enhancer, but we do not
establish that this event is necessary for regulation of Fizz1 gene expression. Our efforts to test
this requirement by developmental knockout and transient suppression of C/EBPb have thus far
yielded ambiguous results. It is notable that, to our knowledge, a requirement for C/EBPb for
specific gene induction has not been demonstrated in other contexts, including in its wellestablished role in the expression of IL-12 in macrophages in response to LPS. This observation
has been attributed to a high degree of redundancy or compensation by other C/EBP family
members, which may limit our ability to formally demonstrate the requirement of C/EBPb for
control of mechanosensitive gene expression.133 Alternatively, C/EBPb binding may not be the
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driver of gene expression, but rather an indication of other changes, such as chromatin opening
in response to actin dynamics.
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Chapter 5: Conclusions, implications, and future directions
Conclusions
In the studies presented in this dissertation, we set out to understand whether, and if so how,
macrophages sense the extracellular matrix in order to regulate tissue homeostasis and tissue
repair. We established that macrophages sense changes in the mechanical properties of the
extracellular matrix and that ECM mechanosensing regulates a specific subset of the macrophage
gene expression program involved in tissue repair. We then determined that macrophages sense
ECM mechanics in a novel, integrin-independent fashion that is mediated through cytoskeletal
responses to the mechanical environment. We learned that macrophage growth factor signaling
converges on these same cytoskeletal dynamics to regulate the same gene expression program.
Finally, we discovered that these changes in the actin cytoskeleton are translated to changes in
chromatin accessibility and site-specific binding of the transcription factor C/EBPb to regulatory
elements of target genes (Figure 5.1).

These studies have revealed several novel elements of macrophage biology and its interaction
with the tissue environment. They also have broader conceptual implications and raise new
questions that I hope will spark future fruitful studies by other investigators. In this chapter, I
discuss these implications and promising areas of future investigation.
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Figure 5.1. Model of cytoskeletal integration of ECM mechanics and MCSF signaling in
macrophages
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Implications and future directions
Identity and tissue specificity of macrophages
During the last decade, one of the major areas of interest and progress in the field of macrophage
biology has been how tissue-resident macrophages acquire their tissue-specific identities.57,63,134–
138

These identities arise from a combination of ontogeny (the developmental origins of the

macrophage in the yolk sac, fetal liver, or bone marrow), together with specific signals that
macrophages receive within the tissue. Lavin and colleagues demonstrated that the chromatin
landscape controlling tissue-specific macrophage gene expression programs is predominantly
dictated by the local tissue environment and could be induced in donor bone marrow-derived
cells or even reprogrammed in tissue-resident macrophages transplanted from one tissue into
another tissue.63 Most of the local signals involved in this specification of tissue-resident
macrophage identity remain unidentified, and to date, those that have been identified are all
soluble signals, such as retinoic acid in the specification of peritoneal macrophages and heme in
the specification of red pulp macrophages in the spleen.135,139

However, the tissue architecture, ECM composition, and mechanical properties of different
organs also vary widely, and we can predict that these features of the ECM might provide critical
information about the local environment that may guide macrophages’ tissue-specific identities.
In this study, we have established that macrophage mechanosensing of the ECM can control
chromatin availability and gene expression programs. Extending this principal to the question of
macrophage tissue specification would be a natural next step. It would also be an extension of
the work by Engler and colleagues showing that mesenchymal stem cell differentiation can be
specified by mimicking the mechanical stiffness of different tissues.11
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We can imagine that the mechanical properties of tissues may not only provide information
about the specific type of tissue that the macrophage is entering, but may also play an essential
role in driving the differentiation step from monocytes to macrophages in general. Monocytes are
produced in the bone marrow and circulate in the blood. They become macrophages when they
enter a tissue, which coincides with a fundamental change in their mechanical environment, from
fluid (with flow) in the bloodstream, across an endothelial barrier (which requires integrinmediated attachment),103 into a three-dimensional tissue with extracellular matrix surrounding
the cell. I hypothesize that the cytoskeletal changes that happen in this process may provide key
signals to induce macrophage differentiation. These signals from the ECM may converge with
growth factor signaling, similar to what we have found in the present studies. MCSF drives
macrophage differentiation, and we have established here that a subset of its effects on gene
expression are mediated through its remodeling of the cytoskeleton. Intriguingly, macrophage
differentiation can be achieved in vitro from monocytes without MCSF, and these methods, such
as lysophosphatidic acid (LPA) and phorbol 12-mystate 13-acetate (PMA), also induce
cytoskeletal remodeling in macrophages and may require C/EBPb.140,141 C/EBPb has been
identified as a pioneer transcription factor, working together with PU.1 to shape the chromatin
landscape to establish and maintain macrophage identity.132,142 These hypotheses are
experimentally tractable and could begin with differentiating macrophages from either bone
marrow precursors or monocytes on plastic dishes (as usual) compared to collagen gels or
polyacrylamide gels of different stiffnesses and comparing the effects on macrophage
transcriptional and chromatin landscapes by RNAseq, ATACseq, and ChIPseq.
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Tissue repair and fibrosis
This study began with the question of why tissue repair fails to turn off in fibrotic diseases. We
ultimately focused on the fundamental question of how macrophages sense the tissue
environment, rather than the specific pathologic context of fibrosis, but our results reveal
biological mechanisms that may have important implications for the biology of fibrosis.

The gene that showed the most dramatic and consistent regulation by the ECM is Fizz1. As
discussed in Chapter 2, macrophage-derived, IL-4-induced Fizz1 has been shown to be critical
for tissue repair in the skin, due to its effect on fibroblast collagen deposition.28 Fizz1 likely
plays a similar role in the lung, where it is also potently induced by IL-4 upon tissue injury and
required for effective ECM deposition.66–68 We confirmed that FIZZ1-conditioned media
stimulates collagen and aSMA expression in fibroblasts, suggesting the induction of a
myofibroblast-like phenotype, cells that produce and contract ECM and drive tissue repair and
fibrosis. These data suggest that macrophages may respond to increasing ECM stiffness by
suppressing further ECM deposition and perhaps inducing a pro-resolution program.
(Interestingly, we found that the matrix metalloprotease Mmp12 was generally regulated in an
inverse fashion to Fizz1 by tissue stiffness and cytoskeletal perturbations, though there were
some exceptions to this pattern.) This would position macrophages to exert negative feedback on
the repair process and to prevent unrestrained ECM deposition that would otherwise lead to
fibrosis. It could put a check on the positive feedback loop that has been described in fibroblasts,
wherein increasing ECM stiffness induces further ECM production and matrix stiffening.
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These considerations return us to the key question of whether there is a common vulnerability to
the development of fibrotic diseases. If fibroblasts, left to their own devices, would perpetuate a
positive feedback loop of ECM accumulation, perhaps fibrosis arises when the negative feedback
provided by macrophages or other cells fails. Regulation of Fizz1 may be one example of a
broader repertoire of mechanisms that have not yet been identified. Indeed, studies in the lung
and liver have shown that macrophages are required for effective resolution of tissue repair and
have identified mechanisms of ECM remodeling that may contribute to this function.26,27,47,51
Defects in these effector responses, or in macrophage sensing of the ECM to regulate these
responses, could be central to the development of fibrosis.

One of the challenges, however, for establishing this and many other hypotheses regarding the
pathogenesis of fibrotic diseases, is that we don’t have the tools to identify these defects in the
context of human disease, and most models of fibrotic disease, such as the intratracheal
bleomycin model, are better understood as tissue repair models than fibrosis models. Because the
mice are normal, they respond normally to the tissue injury caused by bleomycin. They have an
acute inflammatory phase (roughly 0-7 days), then progress to a phase of dense ECM deposition
(around 14-21 days), which is what is typically labeled “fibrosis”, but then ultimately progress to
a resolution phase (around 28-35 days) characterized by degradation and remodeling of the
ECM. This type of model is very useful for studying the normal progression of tissue repair, and
we used it in this capacity, but it does not tell us anything directly about why some individuals
instead develop persistent ECM deposition and fibrotic disease.
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In our studies, we found fortuitously that MCSF converges on the same gene expression program
characterized by Fizz1. This finding raises the question of why MCSF should suppress a profibrotic program in macrophages. MCSF in tissues can be produced by multiple cell types, but
fibroblasts are a major source of MCSF and form a regulatory circuit with macrophages to
control cell numbers within the tissue.20 One possibility, then, is that the concentration of MCSF
acts as a proxy for the number of fibroblasts in the local tissue environment. The accumulation of
fibroblasts, like the accumulation of the extracellular matrix they produce, could serve as a signal
to macrophages to exert negative feedback on the repair process. In support of this model, we
found that co-culture of BMDM with increasing numbers of L929 fibroblasts effectively
suppressed Fizz1 and induced Arg1, just like increasing concentrations of MCSF.

Mechanosensing
The finding that macrophages can sense the mechanical properties of the extracellular matrix
was an important step in our understanding of macrophage biology, but not a particularly
surprising one, given our knowledge that many other cell types are mechanosensitive. Recently,
other groups working in parallel have published related findings, including that macrophages can
sense cyclic stretch and spatial confinement and that both macrophages and T cells can sense
extracellular matrix stiffness to regulate inflammatory responses.143–146 The latter studies on
ECM mechanosensing, however, propose that these immune cells use the same mode of
mechanosensing—based on adhesion to the ECM and regulation of YAP translocation—as
mesenchymal cells like fibroblasts. Perhaps the most provocative finding in our studies is that
macrophages can employ an entirely different mode of ECM mechanosensing that is not based
on integrin-based adhesions.
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The discovery in 2008 that leukocytes can migrate in three-dimensional tissues without adhering
to the ECM opened up a new way of thinking about cell migration.103 It was made possible by
studying migration within 3D model systems, in particular collagen gels, that resemble the tissue
environment, because on two-dimensional surfaces leukocytes follow the same rules of cell
migration as mesenchymal cells. As I discussed at length in Chapter 3, we believe that
macrophage mechanosensing in 3D environments is similarly adhesion-independent and that, as
a general rule, cell migration and mechanosensing are closely linked biological processes that
employ common mechanisms. As in the discovery of integrin-independent migration, using a 3D
model system was essential for our identification of this distinct mode of mechanosensing.

This discovery raises at least two fundamental questions for further exploration. First, what are
the relevant mechanical properties that are sensed by macrophages in a three-dimensional
context? On a 2D surface, we know that macrophages can sense changes in substrate stiffness
alone. However, in a 3D context, manipulating the stiffness of the environment also meant
changing the architecture of the extracellular matrix, such as its pore size. Macrophages may
sense stiffness per se, or they may sense another parameter like physical confinement. As I
discussed in Chapter 3, I predict that adhesion-independent mechanosensing operates in a
manner that is essentially the opposite of adhesion-based mechanosensing. Instead of pulling on
the extracellular matrix, I suspect that macrophages interpret their environment by pushing
against it as they migrate. Instead of tension being the relevant force, I hypothesize that
compression is the relevant type of force. This mode of mechanosensing is consistent with what
we understand about the mechanobiology of adhesion-independent migration, it would not
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require receptor-mediated interaction with the ECM, and it would allow cells to integrate
properties of their environment like stiffness and confinement. It would also fit with a consistent
theme of our studies, which is that, when it comes to the extracellular matrix and the
cytoskeleton, macrophage biology follows a distinct set of rules from those defined in adhesive
cell types like fibroblasts. The critical mechanical experiments to determine whether
macrophages indeed sense compressive forces remain to be done, and I hope that they will be
taken up by future investigators.

Second, if we extend the analogy with cell migration, we know that diverse types of leukocytes
employ a common set of mechanisms to achieve rapid migration through tissues.103 Thus, we can
hypothesize that they might also employ common mechanisms of mechanosensing. I would
predict that dendritic cells, B cells, T cells, and other leukocytes might similarly sense
mechanical compression in a receptor-independent fashion mediated through cytoskeletal
remodeling, in order to control their transcriptional programs and tissue-specific functions.

The cytoskeleton
Perhaps the most far-reaching implications of these studies involve the role of the cytoskeleton in
cell biology. Throughout our experiments, our data consistently pointed us toward a surprisingly
central role of the cytoskeleton in the biological processes we were studying. By observing cells
microscopically across many dozens of experiments, I began to notice that the morphology of
macrophages closely tracked with their gene expression profiles. This became even more clear
when I began performing live cell microscopy and was able to watch their dynamic patterns of
migration and extension and retraction of membrane protrusions. I realized that I could observe
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the effects of a given stimulation or inhibitor on macrophage morphology and migration and
reliably predict whether it was going to affect the gene expression program characterized by
Fizz1 (which I would then assay, often in the same experiment, by qPCR). The effect of MCSF
on both the cytoskeleton and gene expression was the most striking example of this pattern and
helped drive my intuition that the cytoskeleton was at the crux of the biology we were
investigating.

Our findings directly raise questions about the macrophage cytoskeletal dynamics involved in
mechanosensing and growth factor signaling, and they suggest broader conceptual questions
about the cytoskeleton as a cellular signaling hub. In our studies, we were not able to determine
what exactly is measured about the actin cytoskeleton to relay information about the tissue
environment. In the case of MRTF, the best-studied example of a transcription factor that reports
on the state of the cytoskeleton (discussed in Chapters 1 and 4), G-actin binds to MRTF to
sequester it in the cytoplasm, so the concentration of G-actin is thought to be the critical
parameter of the cytoskeleton that is sensed. In our studies, we found that the MRTF inhibitor
CCG-203971 dramatically increased macrophage membrane protrusions, but it potently
suppressed not only the specific mechanosensitive gene expression program characterized by
Fizz1, but also other IL-4 induced genes like Arg1. Interestingly, this inhibitor has not been
shown to act on MRTF directly and may act instead through its effects on the cytoskeleton. It is
also notable that, based on conversations with other investigators, it inhibits not only MRTF/SRF
target genes, but also other unrelated genes in fibroblasts, suggesting that it may be rather nonspecific, which could explain its effect on both Fizz1 and Arg1. More compelling evidence that
our gene expression program is likely not MRTF-dependent came from immunofluorescence and
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cell fractionation experiments that did not show a clear translocation of MRTF from the nucleus
to the cytoplasm when cells were treated with latrunculin A (which causes almost all actin to be
in the monomeric G-actin state). These data suggest that MRTF may follow different sets of
rules in macrophages than mesenchymal cells, similar to other differences in cytoskeletal and
mechanobiology that we have observed. Interestingly, however, one group has implicated
MRTF/SRF in macrophage sensing of physical confinement.144

Whether or not MRTF plays a role in macrophage mechanosensing, it seems unlikely that a static
parameter like the concentration of G-actin or F-actin/G-actin ratio is the relevant property of the
cytoskeleton that controls the downstream gene expression program that we have identified.
While most stimuli that suppressed Fizz1 also induced dendritic macrophage morphology, with
long F-actin protrusions, latrunculin A was an interesting exception to this rule. It caused
macrophages to become round, with very little F-actin (confirmed by immunofluorescence with
phalloidin, which binds F-actin polymers). If the amount of F-actin or G-actin, or some other
static feature of cell morphology, were the relevant parameter, then latrunculin A would be
expected to cause the opposite effect on gene expression from stimuli like MCSF, blebbistatin,
and GSK3 inhibition that induce dendritic morphology. Instead, we hypothesize that a dynamic
feature of the actin cytoskeleton, such as the polymerization or depolymerization rate of actin
filaments (or the force of actin retrograde flow involved in this process), is sensed. In lowcollagen gels and other high-Fizz1 states, cells migrate quickly and form shorter protrusions that
appear to turn over at a rapid rate. In low-Fizz1 states, like high-collagen gels or with MCSF or
blebbistatin treatment, cells have decreased migration and form long membrane protrusions that
turn over at a slower rate. Similarly, after treatment with latrunculin A, cell migration and actin
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turnover are potently inhibited, and Fizz1 expression is dramatically suppressed. (Interestingly,
with nocodazole treatment, which inhibits microtubule polymerization, macrophages migrate but
fail to retain cellular integrity because the microtubule network regulates the actin cytoskeleton.
As a result, the actin protrusions in different portions of the cell appear to go rogue, losing their
central coordination and ultimately causing cell fragmentation. The reason for Fizz1 suppression,
in this case, may have to do with an inability to relay the properties of actin dynamics in the
cytoplasm to the nucleus, either because of cell fragmentation or because the microtubule
network plays an essential role in that process, as well.) Altogether, our data suggest that a
dynamic property of the actin cytoskeleton is measured by the cell in order to regulate
downstream signaling, chromatin availability, or transcription factor activity. Our work has
revealed a fascinating puzzle of macrophage cytoskeletal biology and its control of gene
expression that I believe will yield many more important insights in the future.

While I have emphasized the differences between macrophage and fibroblast biology throughout
this dissertation, it is also likely that what we have learned here about macrophage
mechanosensing and cytoskeletal biology has lessons for the biology of non-hematopoietic cell
types. For instance, while we generally think of fibroblasts as sensing ECM mechanics through
integrins, which then signal downstream through mediators like focal adhesion kinase, this kind
of linear signaling pathway may be the exception rather than the rule. In studies on YAP as a
mechanosensor, the upstream sensors and signaling pathways leading to YAP activation are
generally not identified. Integrins are likely required, but there is not a clear connection between
them and YAP. A different way of thinking about this biology is that it is governed by the state
of the cytoskeleton. Integrins are required for fibroblast adhesion to their environment, and
91

binding to and exerting tension on a stiff substrate causes reciprocal changes in the fibroblast
cytoskeleton that are visible as increased cell spreading. I suspect that it is these changes in the
cytoskeleton itself that are directly or indirectly sensed by YAP. There has recently been very
interesting progress in this direction,147 though as in macrophages, it remains to be determined
what specific cytoskeletal parameters are monitored and how this is translated to YAP
localization and activity.

Finally, our studies raise a deep conceptual question: Why does the cytoskeleton act as an
integrator of diverse types of signals? In Chapter 4, I proposed several specific reasons why it
may be advantageous for biochemical signals to act through effects on the cytoskeleton. Here, I
will take a broader view that the cytoskeleton may act as a central hub of cell biology.

The cytoskeleton is one of the most ancient features of eukaryotic cells. It enables fundamental
cellular activities such as cell movement and feeding in unicellular amoebae and, in multicellular
organisms, coordinates similar functions of cell migration and phagocytosis, as well as
everything from the uptake and release of cellular contents for cell-cell communication to cell
proliferation to the cellular organization that allows for the creation of intact layers of epithelial
and endothelial cells.148 Much of cell biology has evolved around these core cellular functions
and, since evolution builds upon what is already present, signaling pathways have likely been
layered onto the existing cytoskeletal dynamics involved in those cellular processes. We can
imagine that the cytoskeleton may have become a signaling hub over the course of evolution. I
would also suggest that the state of the cytoskeleton offers a key indicator of the state of the
cell—whether migrating or stationary, fixed in or detached from a sheet of cells, proliferating or
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quiescent, as well as far more subtle changes in cell state. In order for the cell to perform almost
any process, the cytoskeleton likely has to be in a compatible state. Thus, it makes sense that
there should be close coordination between the dynamics of the cytoskeleton and the signaling
that controls gene expression and other cellular functions. This role for the cytoskeleton is, I
propose, dramatically under-appreciated at present, in large part because of the difficulty of
studying the dynamics of the cytoskeleton and the very non-linear logic involved in the
regulation of cytoskeletal biology. These features do not lend themselves to neat biological
stories, but I would posit that there is an enormous amount of fundamental biology to be
unlocked by understanding how the cytoskeleton communicates biological information and
coordinates biological processes that have, up to now, appeared entirely independent from it.

To highlight this point, I will make two final observations. First, there has been a major trend in
recent years toward the field of immunometabolism. Metabolism had until recently been an area
of biochemistry that appeared to have little bearing on immunology. But it now appears to play a
role in nearly every immunologic process. The explanation for this, I believe, is similar to what
we have described about the role of the cytoskeleton in cell biology: Metabolic processes are so
ancient and fundamental to cellular function—and are both a critical indicator of cell state and an
essential element of most cellular processes—that they have become a hub for the regulation of a
wide diversity of cellular functions. I would suggest that, if we begin to look, we may find that
the cytoskeleton plays a similarly ubiquitous role, for very similar reasons.

Second, I would point out that cell morphology—an easily accessible, if crude, indicator of the
state of the cytoskeleton—is reliably altered by signals that activate cells and induce
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transcriptional changes and other cellular responses. IL-4 and LPS, for instance, each induce
distinct, stereotypical morphologic changes in macrophages, the purpose of which has never
been defined. In our experiments, TGFb, Wnt3a, PDGFb, and Oncostatin M treatment of
fibroblasts all induced both distinct morphologic and distinct transcriptional responses. Turning
to the clinical realm, we have appreciated for decades that cancer cells can be reliably identified
histologically, in large part based on their morphology. This is a remarkable fact, given the
diversity of cancer drivers, and suggests that the cytoskeleton must be in a particular state to
permit oncogenic transformation or to facilitate cancer cell growth or survival. Thus, it seems to
be a general rule that changes in cell state are accompanied by changes in the cytoskeleton that
can be detected by cell morphology. Perhaps, in the coming years, we will begin to attend to and
to understand the significance of this intimate relationship.
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Chapter 6: Perspectives on homeostasis, inflammation, and tissue biology
A version of this chapter has been published as a review article:
Meizlish ML*, Franklin RA*, Zhou X*, Medzhitov R. Tissue homeostasis and inflammation.
Annual Review of Immunology. 2021; 39. https://doi.org/10.1146/annurev-immunol-061020053734
*Contributed equally

Abstract
There is a growing interest in understanding tissue organization, homeostasis, and inflammation.
However, despite an abundance of data, the organizing principles of tissue biology remain poorly
defined. Here, we present a perspective on tissue organization based on the relationships between
cell types and the functions that they perform. We provide a formal definition of tissue
homeostasis as a collection of circuits that regulate specific variables within the tissue
environment, and we describe how the functional organization of tissues allows for the
maintenance of both tissue and organismal homeostasis. This leads to a natural definition of
inflammation as a response to deviations from homeostasis that cannot be reversed by
homeostatic mechanisms alone. We describe how inflammatory signals act on the same cellular
functions involved in normal tissue organization and homeostasis, in order to coordinate
emergency responses to perturbations and ultimately return the system to a homeostatic state.
Finally, we consider the hierarchy of homeostatic and inflammatory circuits and the implications
for the development of inflammatory diseases.
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Introduction
Homeostasis and inflammation are conventionally described as opposing states of biological
systems, typically associated with health and disease, respectively. This understanding has deep
historical roots that can be traced to a debate between Rudolf Virchow and Elie Metchnikoff, two
founding figures in the study of inflammation. Virchow viewed inflammation as a pathological
phenomenon, which gave rise to the perspective that prevails to this day. Metchnikoff, on the
other hand, had the insight that the vascular changes responsible for the cardinal signs of
inflammation were not a pathological accident of biology but rather were induced on purpose, in
order to deliver phagocytes to the site of infection.149 Moreover, Metchnikoff conceived of a
spectrum of biological states, from homeostasis to physiological inflammation to—only at the
extreme—pathological inflammation and immunity.150 To refer to homeostasis, Metchnikoff
used the term harmony-disharmony balance; the term homeostasis was not coined until decades
later, in 1929, when Walter Cannon published his seminal paper defining homeostasis and its
mechanisms.151 However, Metchnikoff’s insights, identifying a spectrum from homeostasis to
inflammation, did not gain much traction. (Perhaps his disagreement on this issue with the
undeniable authority of Virchow did not help.) One unfortunate consequence was that for the
next century inflammation was studied primarily in the context of pathology, largely
disconnected from physiology.

The concept of homeostasis plays a central role in our understanding of mammalian physiology.
Many aspects of systemic homeostasis are now understood in great detail. The picture is much
less clear when it comes to homeostasis at the tissue level, where a lack of formal definitions has
led to ambiguity and obscured important biological mechanisms. This problem is amplified by
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the largely descriptive knowledge of tissue organization. In this review, we discuss a functional
perspective on tissue organization and its relationship to tissue homeostasis and inflammation.
Based on that framework, we revisit Metchnikoff’s idea of a homeostasis-inflammation spectrum
and discuss the hierarchy of cellular, tissue, and organismal levels of homeostasis and
inflammation.

Basic principles of tissue organization
At first glance, mammalian tissues appear very different from one another. The skin, lungs, liver,
and bone have distinct gross anatomy, cellular composition, and organization. Yet, each of these
tissues is organized according to the same principles. We can understand this fundamental
organization by considering the primordial design of multicellular tissues. The earliest metazoan
tissues, like those of our common ancestors with Ctenophora and Cnidaria, consisted of
epithelial and mesenchymal cells. The layer of epithelial cells created a barrier that separated the
internal environment of the organism from the external environment, in order to defend against
external threats and maintain internal homeostasis. This was the primary function of these
primordial tissues. The mesenchymal cells provided the tissue with structural integrity and
organization, through the production of extracellular matrix (ECM) and soluble signals to the
epithelial cells. These were supportive functions that allowed the epithelial cells to perform the
primary barrier function.3–5 This primordial epithelial-mesenchymal tissue unit illustrates an
important design principle that is conserved in modern multicellular organisms: Cells within a
given tissue fall into two functional categories, (a) primary cells, responsible for performing the
primary function of the tissue, and (b) supportive cells, responsible for performing supportive
functions, which facilitate the performance of the primary function.
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As numerous specialized cell and tissue types appeared over the course of evolution, the basic
tissue design composed of primary and supportive cell types was preserved and elaborated. Each
tissue or organ is specialized to perform one or more essential functions for the organism. The
skin, for instance, serves primarily as a barrier, the lung functions to exchange oxygen and
carbon dioxide, the liver regulates systemic metabolism, and bone provides structural integrity
and organization for the body. As in primordial tissues, each of these tissues contains a cell type
dedicated to performing the primary function of the organ. These include specialized epithelial
cells in the skin, lung, intestines, kidney, and liver; neurons in the brain; and cardiomyocytes in
the heart. All of the other cells within the tissue are supportive cells, which serve to optimize the
performance of the primary function by creating the appropriate conditions within the tissue.
Examples of these supportive components include endothelial cells, pericytes, and smooth
muscle cells, which form vasculature to deliver oxygen and nutrients to the primary cell;
fibroblasts, which (as in primordial tissues) produce growth factors and ECM to position the
primary cells and provide the necessary mechanical properties to facilitate the particular function
of the organ; stem cells, which replenish the primary cell type; neurons innervating the tissue,
which transmit critical information to and from other parts of the organism; and tissue resident
macrophages, which sense and respond to changing conditions within the tissue to maintain an
optimal environment (Table 6.1).22 While these cell types play supportive roles in most organs,
they can also serve the primary function in other, specialized organs. For instance, endothelial
cells are the primary cell type in large blood vessels like the aorta, osteoblasts (a specialized type
of fibroblast) are the primary cell type in bone and cartilage, hematopoietic stem cells are the
primary cell type in the bone marrow, and neurons are the primary cell type in the central
98

nervous system. We can think of these organs as elaborations of the supportive functions that
those cells normally serve. In these cases, the supportive functions (such as nutrient transport)
are outsourced to whole organs (such as the aorta), in order to adequately supply multiple tissues
or the organism as a whole.
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CELL TYPE

CORE FUNCTIONS
Barrier function

Epithelial
cells

CHARACTERISTIC EXAMPLES
Skin epithelial cells: External environment
Intestinal epithelial cells: Intestinal contents

Transport: Absorption

Small intestinal epithelial cells: Nutrients
Type 1 alveolar epithelial cells: Gases
Kidney epithelial cells: Electrolytes

Transport: Secretion

Goblet cells: Mucus
Hepatocytes: Plasma proteins
Paneth cells: Antimicrobial peptides
Type 2 alveolar epithelial cells: Surfactants

Sensing
ECM production

Enterochromaffin cells: Metabolites & noxious stimuli
Osteoblasts: Bone matrix

Stromal cells
Growth factor production

Endothelial
cells
Smooth
muscle cells

Barrier
Transport
Contraction and
Relaxation

Phagocytosis

Macrophages
Sensing

Niche cells: Stem cell survival factors
Vascular endothelium: Fluids, plasma proteins, &
solutes
Pulmonary capillaries: Gases
Vascular smooth muscle: Blood flow
Intestinal smooth muscle: Peristalsis
All macrophages: Microbes & apoptotic cells
Alveolar macrophages: Surfactants
Microglia: Cellular debris & unnecessary neuronal
structures
Splenic red pulp macrophages: Red blood cells
Intestinal macrophages: Microbes
Splenic red pulp macrophages: Heme

Lipid storage and release

White adipocytes

Thermogenesis

Brown adipocytes

Sensing

Sensory neurons

Adipocytes

Neurons

Computation
Control of target tissues

Stem cells

Self-renewal and
Differentiation

Interneurons
Motor neurons

Hematopoietic stem cells
Intestinal stem cells

Table 6.1. Cell types, their core functions, and characteristic examples within specific tissues
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These examples highlight an important principle: The distinction between primary and
supportive cell types does not describe intrinsic characteristics of cells but rather the relationship
between cells (Figure 6.1). To illustrate this point, we can consider a blood vessel within an
organ, such as the gut. In the blood vessel, endothelial cells serve the primary function, creating a
barrier between the systemic circulation and the tissue and regulating the transport of specific
contents. Smooth muscle cells and pericytes are supportive cells that optimize those functions. If
we zoom out to the whole tissue, though, those same vascular endothelial cells are playing a
supportive role, delivering oxygen to the intestinal epithelial cells, which serve the primary
function of nutrient absorption. If we further zoom out to the organismal level, intestinal
epithelial cells are playing a supportive role, supplying nutrients for the organism as a whole. We
can see from this example that the terms primary and supportive are relational rather than
absolute and also that the relationship of supportive to primary components exists along a
hierarchical axis. Each biological component supports the functions of a higher-order unit
(Figure 6.1). This hierarchy of functions is not unique to biological systems and can be seen, for
instance, in the structure of large companies. Each department has supportive personnel that
optimize the performance of that department, and the department in turn supports the overall
function of the company. The departments are analogous to tissues, and the company is
analogous to an organism. This hierarchical support structure allows for the multiscale
organization of biological systems, beginning from subcellular units and building up to cells,
tissues, organ systems, and organisms.
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Figure 6.1. Hierarchy of supportive and primary cellular functions
Using the hierarchy of blood vessels to intestine to organism, the relationships between supportive and
primary functions are illustrated. Within the blood vessel, pericytes (A) are supportive for the primary
barrier and transport functions performed by endothelial cells (B). At the level of the intestine, endothelial
cells play a supportive role for the primary function of nutrient absorption performed by intestinal epithelial
cells (C). At the organismal level, the intestinal epithelium supports primary functions of the organism as a
whole (D). Rectangles represent supportive functions, and circles represent primary functions. Colors
denote primary to supportive relationships.
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Core functionalities of cell types
Most tissues in complex metazoans are composed of multiple cell types, each specialized on one
or more core functionalities (Table 6.1). For instance, the core functionalities of epithelial cells
are barrier, transport (absorption and/or secretion), and environmental sensing, while the core
functionalities of smooth muscle cells are contraction and relaxation. The diverse array of
vertebrate cell types, with their distinct core functions, provides a biological tool kit for building
tissues. Each tissue uses a unique complement of these same fundamental building blocks to
achieve the particular function of that organ and to optimize its performance.

Comparing two barrier tissues, those of the lung and the gut, exemplifies how these same basic
cellular units are utilized across different tissues, as well as the variations in how they can be
deployed. The primary functions of both the lung and the gut are transport and barrier functions.
However, they perform these functions in different contexts and for different purposes, which
has driven specialization of the basic epithelial unit for each organ in several ways. First, both
epithelia are specialized for transport, but of entirely different kinds of substances. Intestinal
epithelial cells must absorb nutrients, for which they express specific enzymes and
transporters.152 Alveolar epithelial cells must exchange gases (oxygen and carbon dioxide), so
they have a flattened morphology to minimize the distance for diffusion.153 Second, both
epithelia are adapted for a barrier function, separating the internal from the external environment
and defending against pathogens. This function is supported by further specialized subsets of
epithelial cells that have a dedicated secretory function: Goblet cells in both organs secrete
mucus that lines the epithelial barrier and helps prevent the penetration of microbes. In the lung,
type 2 alveolar epithelial cells solve the lung-specific problem of surface tension by secreting
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surfactants, and in the gut, Paneth cells secrete antimicrobial peptides to deal with ubiquitous
exposure to microbes.154,155 Third, both epithelia have distinct, specialized sensory cells. For
example, the intestinal epithelium contains enteroendocrine, enterochromaffin, and tuft cells that
detect nutrients and noxious substances and produce hormones, neurotransmitters, and cytokines
to coordinate appropriate responses to the luminal contents of the gut.156,157

Supportive cells are also deployed in each tissue to facilitate those unique primary functions and
to help address the particular challenges faced by each organ. To help regulate the large
microbial community in the intestines, there is an extensive and highly organized population of
gut-resident immune cells.155 In the lung, alveolar macrophages support the critical surfactant
biology described above by sensing surfactant levels and appropriately clearing surfactant from
the alveoli, balancing surfactant production by epithelial cells.158 The fibroblasts in each tissue
produce ECM that confers distinct mechanical properties, optimized for cycles of inspiration and
expiration in the lung and distention and motility in the gut.159–161 Endothelial cells supply
oxygen and nutrients from blood to both tissues, but in the lung they also have the special
function of absorbing oxygen from the air and off-loading carbon dioxide. To achieve this, the
endothelial cells of pulmonary capillaries are closely apposed to the alveolar epithelial cells,
sharing a single basement membrane to minimize the distance for gas diffusion.162

Both organs pair smooth muscle with endothelium (with the exception of capillaries and
postcapillary venules) to regulate the diameter of blood vessels. However, this partnership
follows tissue-specific rules. In the gut, like elsewhere in the body, hypoxia stimulates smooth
muscle relaxation and thus vasodilation to increase blood flow and oxygen delivery to the tissue,
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correcting the hypoxia.163 In contrast, in the lung, hypoxia stimulates smooth muscle contraction
and thus vasoconstriction to prevent blood flow to regions of the lung that are not being wellventilated. The failure to match oxygenated air with blood flow in the lung is called
ventilation/perfusion mismatch and is a major cause of hypoxemia.164 Each organ also deploys
smooth muscle in other contexts. The lung pairs smooth muscle with bronchial epithelial cells to
regulate the caliber of the airways, similar to the role of smooth muscle in blood vessels. Smooth
muscle in the gut uses the same core functionalities of contraction and relaxation to a very
different end, generating coordinated waves of peristalsis that cause directional movement of the
intestinal contents. Neurons in both organs, in turn, have the function of controlling smooth
muscle contraction. They also relay local information, from sensory enteroendocrine cells in the
gut, for instance, to other parts of the organism.165,166 Finally, each tissue has stem cells that are
located within the organ’s basic units of organization, the villi in the intestine and the alveoli in
the lungs, which allows them to regenerate regularly and in response to damage.155,167

Like the tissues that make up the lung and gut, each tissue in an organism can be described as an
assembly of complementary core functions. We elaborate on some additional examples below, as
we detail how these core functions are modified in the context of homeostasis and inflammation.
For now, we can make two important generalizations based on the discussion above. First, there
is intimate coordination between the primary and supportive components of tissues because the
supportive functions exist to facilitate and optimize the primary functions. As a consequence,
certain supportive and primary cell types are typically paired together. Cell types specialized in
transport (like epithelium or endothelium) are typically paired with smooth muscle to control the
flow of luminal contents, as well as neurons to control the contraction of the smooth muscle.
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Pericytes also regulate endothelial transport, in some cases together with other stromal cells,
such as astrocytes in the brain to maintain the blood-brain barrier and podocytes in the kidney to
control the filtration of blood into urine.168–170 Epithelial cells that serve a barrier function are
paired with immune cells to prevent infection. Primary cells specialized in sensing are often
paired with afferent neurons to integrate and communicate that information to other parts of the
organism. Second, the role of the supportive cells within a tissue is often to maintain the internal
environment of the tissue—such as the composition of ECM and the concentrations of oxygen,
nutrients, and waste products—in an appropriate and stable state. In a similar fashion, primary
cells of each organ regulate internal conditions of the whole organism, like blood pressure and
the concentrations of ions and metabolites. Thus, supportive cells are responsible for maintaining
homeostasis on the tissue level, while primary cells are responsible for maintaining homeostasis
on the organismal level.

Tissue homeostasis
Tissue homeostasis is a term that is often used to describe a normal, steady-state, or uninflamed
condition of a tissue. However, this loose definition obscures important features of tissue
biology. To arrive at a more precise definition of tissue homeostasis, we first discuss the
components of a homeostatic circuit and examples of systemic and cellular homeostasis, which
are better understood, and then examine these concepts on the tissue level.

Homeostasis describes the active maintenance of certain quantitative characteristics of the
system, known as regulated variables, within a desired range. The homeostatic circuit is
structured to maintain them at a stable level, close to a target value known as the set point. In
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order to be maintained, the values of regulated variables have to be monitored by specialized
sensors and corrected by effectors. Sensors must be able to communicate with effectors through
dedicated signals that report on changes in the regulated variable. Together, regulated variables,
sensors, signals, and effectors make up a homeostatic circuit (Figure 6.2a). In the case of
systemic homeostasis, the components of homeostatic circuits are typically well-defined. For
instance, to regulate blood glucose (regulated variable), pancreatic alpha and beta cells serve as
sensors; glucagon and insulin are signals that reflect the glucose concentration; and liver, skeletal
muscle, and adipose are effectors that can correct any deviations of blood glucose levels from a
set point value.171

Cellular homeostasis is not yet understood as completely as systemic homeostasis, since most of
the knowledge comes from studies of cellular stress responses (discussed below). The known
regulated variables of cellular homeostasis include concentrations of various metabolites and
macromolecules, like oxygen, ATP, and proteins, as well as membrane potential and the number
and size of various organelles, like mitochondria, lysosomes, and endoplasmic reticulum (ER).172
The known sensors of these variables are HIF-1a (for oxygen), AMPK (for ATP), HSF1 and
IRE1 (for cytosolic and ER proteins), mTOR and GCN2 (for amino acids), and TFEB (for
lysosomes).173–178 Each of these sensors activates a set of effectors that can correct deviations in
the regulated variables. AMPK activates catabolic metabolism to increase ATP production, the
IRE1-XBP1 pathway regulates ER size (in part through control of lipid synthesis), and TFEB
controls lysosome size and number by inducing expression of lysosome-resident proteins. The
signals that connect sensors and effectors in cellular homeostasis are either signaling pathways
that control activity of effectors or transcription factors that control their expression.
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Tissue homeostasis should be similarly defined in terms of regulated variables, sensors, signals,
and effectors.22 Regulated variables at the tissue level include local concentrations of oxygen and
nutrients, ECM density and stiffness, osmolarity and pH of interstitial fluid, and cell numbers
and composition.19 The sensors for these variables include tissue-resident macrophages and
sensory neurons.179,180 Sensing mechanisms of some of the regulated variables are well
understood, particularly when the molecular sensors are the same as in cellular homeostasis, such
as HIF-1a for oxygen and NFAT5 for osmolarity.181,182 In tissue homeostasis, however,
activation of these sensors results in the production of paracrine signals that engage effectors on
the tissue level: HIF-1a stabilization leads to VEGFA production to induce angiogenesis, which
increases oxygen delivery,183 while NFAT5 activation leads to VEGFC production to induce
lymphangiogenesis and lymphatic drainage, which reduces osmolarity.184 Interstitial fluid pH can
be sensed by GPR4, GPR65, and GPR68 expressed by endothelial cells, macrophages, and
sensory neurons.185 The mechanisms for sensing many other tissue homeostatic variables, such
as cell number and ECM composition and stiffness, are unknown. It can be predicted, however,
that sensing a deviation in any of these variables will result in production of a paracrine signal
that acts on the appropriate effector cell types to correct the deviation (except when a single cell
type serves as both the sensor and effector for the same variable). In most cases, the specific
homeostatic circuits that control tissue-level variables remain to be defined.

It is important to note that the sensors and effectors in tissue homeostatic circuits are the
supportive cells within tissues. In fact, their supportive functions are largely defined by their
roles in tissue homeostasis. These core functions can be quantitatively dialed up and down by the
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homeostatic signals that communicate between sensors and effectors, allowing supportive cells
that serve as effectors to respond dynamically to the needs of the tissue. The cell types that
perform primary functions within tissues, on the other hand, are the sensors and effectors of
systemic homeostasis. Thus, pancreatic alpha and beta cells have the primary function of sensing
blood glucose, a systemic homeostatic variable, and skeletal muscle, hepatocytes, and adipocytes
are primary cells in their respective organs that function as effectors to correct blood glucose
concentration. This example illustrates a principle that connects tissue organization with
homeostatic circuits: Systemic homeostasis is maintained by primary cells, while tissue
homeostasis is maintained by supportive cells within tissues (Figure 6.2b).

Stress responses
Each homeostatic variable is characterized by a normal range of variation—the maximum
deviation from the set point that can be tolerated. When values of regulated variables change
within that range, homeostatic mechanisms correct them through negative feedback, as discussed
above. Deviations that approach the limits of this homeostatic range put more strain on the
system, resulting in what is commonly referred to as a stress response.186,187 These larger changes
in regulated variables are detected and corrected by the same homeostatic sensors and effectors.
In fact, what we know about cellular homeostasis was learned primarily by studying extreme
perturbations to regulated variables, such as hyperosmolarity, hypoxia, and nutrient deprivation,
or by manipulations that indirectly affect regulated variables, such as treatment with tunicamycin
(glycosylation inhibitor), thapsigargin (calcium ATPase inhibitor), or proteasome inhibitors.
Accordingly, the pathways involved in correcting these cellular perturbations are traditionally
referred to as stress pathways, rather than homeostatic pathways.186 It is important to emphasize,
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however, that cellular stress is just a large deviation of a homeostatic variable nearing the limits
of what can be addressed through homeostatic effector mechanisms. Stress responses are part of
a continuum of homeostatic responses. Yet, the outcomes of stress responses can be qualitatively
different from those of homeostatic responses. In addition to engaging homeostatic effectors to
correct the deviations in regulated variables, stress responses may also suppress processes that
either contribute to these deviations or are incompatible with correcting the deviations. For
example, most cell stress responses inhibit cell proliferation, while homeostatic responses to
normal variations in the regulated variable do not.

Consistent with the hierarchy of homeostatic circuits, stress responses can be engaged at the
levels of the cell, tissue, and organism. All individual cells can detect and respond to stress.
These cell-autonomous stress responses allow individual cells to adapt and survive in changing
environments. For example, the cellular response to hypoxia is initiated by the hypoxia sensor
HIF-1a, which activates transcription of the genes for the glucose transporter GLUT1 and
glycolytic enzymes to promote anaerobic glycolysis (Figure 6.2c).188 This response occurs in all
nucleated cells and is an example of the cellular stress response. However, cell-intrinsic
adaptations to stress provide only short-term solutions, as they do not correct the problem itself.
In this example, the cellular stress response does not eliminate local hypoxia. In multicellular
organisms, cells can also coordinate with one another to perform tissue-level stress responses.
Although all cells can sense stressors such as hypoxia, tissue-level responses generally rely on
cells that have specialized sensory functions, such as tissue-resident myeloid cells and sensory
neurons. In the case of hypoxia, tissue-resident macrophages detect low oxygen levels and
secrete vascular endothelial growth factors and other angiogenic signals to endothelial cells,
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which act as effectors (Figure 6.2d).189 The outcome of this tissue-level response is local
angiogenesis and increased oxygenation of the tissue, thus correcting the low oxygen levels
directly. This response, however, may not be adequate when blood oxygen levels are low (i.e.,
systemic hypoxia or hypoxemia), which requires a stress response on the level of the whole
organism. The sensors of systemic hypoxia are peritubular interstitial fibroblasts in the kidney, as
well as hepatocytes, which detect hypoxia through HIF-1a and HIF-2a and induce expression of
erythropoietin (EPO).190,191 EPO acts on erythroid progenitors in the bone marrow to promote
erythropoiesis and increase oxygen delivery by red blood cells (Figure 6.2e). The example of the
stress response to hypoxia illustrates two points: First, even for the same homeostatic variable,
sensors, signals, and effectors can differ at the cellular, tissue, and organismal levels. Second, it
highlights again that supportive cell types in tissues serve as sensors and effectors to maintain
tissue homeostasis, while the primary cells of tissues function as sensors and effectors to
maintain organismal homeostasis.
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Figure 2. Homeostasis at the level of the cell, tissue, and organism
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Figure 6.2. Homeostasis at the levels of the cell, tissue, and organism
(A) The homeostatic circuit illustrates how regulated variables are maintained within an appropriate
physiological range. Deviations in regulated variables are detected by sensors, which then signal to
effectors to correct the deviation. (B) The interplay between tissue-level and systemic homeostatic circuits
is shown. Supportive cell types within tissues are the sensors and effectors for tissue-level homeostatic
variables. Maintaining these variables in the proper range allows for effective function of the primary cells
within the tissue. Thus, tissue homeostasis is maintained by supportive cells. Conversely, at the systemic
level, primary cells are the sensors and effectors for systemic homeostatic variables. Therefore,
organismal-level homeostasis is maintained by primary cells. (C-E) The regulated variable oxygen is
sensed and maintained at the cellular, tissue, and organismal levels. These pathways are depicted using
the logic of the homeostatic circuit. Abbreviations: E, effector; EPO, erythropoietin; ES, endocrine signal;
PS, paracrine signal; S, sensor; SHV, systemic homeostatic variable; THV, tissue homeostatic variable;
VEGFA, vascular endothelial growth factor A.
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Tissue microenvironment
The framework for tissue homeostasis described above allows us to better define the tissue
microenvironment. Individual cells within tissues are surrounded by a milieu that includes
nutrients, oxygen, metabolic waste products, and the composition and mechanical properties of
neighboring cells and ECM. From the perspective of the individual cell, these are features of
their environment. From a tissue-level perspective, however, these are regulated variables: They
are actively monitored by homeostatic sensors and corrected by effectors. When these variables
deviate to the edges of the homeostatic range, stress responses are mobilized at the cellular and
tissue levels. When these variables are within a normal range, close to the homeostatic set point,
individual cells enjoy an optimal environment.

The notion of a tissue microenvironment became particularly popular in reference to tumors,
which have characteristically altered homeostatic variables. Unrestrained proliferation of cancer
cells within tumors results in oxygen and nutrient depletion and alteration of cell composition
and tissue architecture.192,193 These changes tend to limit proliferation of cells. The deviations in
these regulated variables are sensed by tissue homeostatic sensors, such as tissue-resident
macrophages (in this context referred to as tumor-associated macrophages).194 Various effectors,
like endothelial cells and stromal cells, attempt to correct them, just as they would in normal
tissues. By maintaining tissue homeostasis, the supportive cell types (macrophages, endothelial
cells, and stromal fibroblasts) enable tumor growth, which makes them essential components of
most solid tumors. However, in fast-growing tumors, the homeostatic capacity is eventually
overwhelmed by uncontrolled proliferation of cancer cells, leading to the formation of a necrotic
core at the center of the tumors, where homeostatic alterations are most severe.195,196 The
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extreme deviations and ultimately the loss of tissue homeostasis observed in tumors can also
occur in normal tissues in response to severe perturbations of homeostatic variables that exceed
homeostatic capacity. This can result in cell death and the loss of normal tissue architecture and
function. When this happens, tissues engage in the next line of defense—the inflammatory
response.

Tissue inflammation
Inflammation is usually defined as a response to infection or injury. While this view is certainly
correct, it does not capture the essence of the inflammatory response or explain its role in a wide
range of physiological and pathological conditions. Infection and injury are extreme
perturbations. As a result, they cause inflammatory responses of a magnitude that is readily
observable. However, it is now well appreciated that inflammation can occur without infection or
overt tissue damage. A common theme of conditions that initiate inflammation is the disruption
of cellular and tissue homeostasis.197–200 There are several well-known examples of this: 1) Cells
with disrupted homeostasis that undergo senescence can release inflammatory mediators known
as the senescence-associated secretory phenotype (SASP).201 2) Excessive cell stress, such as
ER, mitochondrial, or osmotic stress, that cannot be handled by effector mechanisms within the
homeostatic regime activates the NLRP3 inflammasome.187 This leads to production of IL-1
family cytokines,198,202,203 as well as ligand-independent activation of tumor necrosis factor
(TNF)-related apoptosis-inducing ligand (TRAIL) receptors.204 In obesity, lipid overload in
adipocytes and hepatocytes causes ER stress and production of inflammatory signals.199 This
type of inflammation, called metaflammation,205 is caused by a disruption of metabolic
homeostasis.
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The pathological roles of these inflammatory responses are well appreciated, as exemplified by
the contribution of ER stress–induced inflammation to metabolic disease and the contribution of
SASP to tumor progression and aging.206–208 However, they also have important physiological
roles that are becoming clearer. For instance, endurance exercise increases production of
proinflammatory cytokines, such as IL-13 and IL-6. IL-13 induces the expression of
mitochondrial and fatty acid oxidation genes in myocytes, which leads to a transition to slowtwitch oxidative muscle fibers and enhanced mitochondrial biogenesis, in order to optimize
energy utilization and adapt to high-endurance exercise.209 IL-6 is produced by myocytes based
on the duration and intensity of physical activity and acts on liver and adipose tissues to regulate
glucose and lipid metabolism, in order to meet long-lasting energy demands.210,211 IL-6 is also
produced by brown adipocytes under conditions of acute psychological stress, in response to
adrenergic stimulation by the sympathetic nervous system, and promotes hepatic
gluconeogenesis to support fight-or-flight responses.212 In these cases, inflammatory cytokines
regulate both tissue-level and systemic adaptations to anticipated physical activity that exceeds
homeostatic demands.

The examples above illustrate the common principle that extreme perturbations of tissue
homeostasis induce inflammation. While deviations of regulated variables within a normal range
are corrected by the homeostatic circuit (including stress responses), extreme deviations of
regulated variables beyond the homeostatic range trigger the inflammatory response (Figure
6.3a). On this view, homeostatic, stress, and inflammatory responses are activated based on the
degree of deviation in the regulated variable, rather than qualitatively different types of
challenges. Thus, homeostasis, stress, and inflammation represent a continuum of responses to
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tissue perturbations. The cellular sensors that trigger these different responses can either be the
same, such as IRE1, which coordinates the cell-intrinsic ER stress response and can also induce
inflammatory signals such as IL-6 and TNF—or distinct, as in the case of the NLRP3
inflammasome, which responds to the most extreme deviations to activate inflammation.186,187,213

Similarly, although the homeostatic and inflammatory signals released by these sensors are
traditionally thought to be distinct, accumulating evidence indicates that many inflammatory
mediators can also function as homeostatic signals. For instance, TNF promotes epithelial cell
proliferation, and IL-6 maintains self-renewal of hematopoietic, mesenchymal and epithelial
stem cells.214–218 Prostaglandins have both inflammatory and homeostatic functions, including
their role in maintaining epithelial barrier integrity.219 Histamine is a potent inflammatory
mediator produced by mast cells and basophils but also plays an important role in controlling
intestinal peristalsis and gastric acid secretion and functions as a neurotransmitter in the brain.220–
223

Whether these signals perform homeostatic or inflammatory functions may depend on their

expression range and the source and target cell types.

In addition to sensing extreme perturbations in homeostatic variables, cells can sense the loss of
tissue homeostasis retrospectively by monitoring its consequences, such as cell death. Cells
undergoing several forms of unscheduled cell death, including necrosis, necroptosis, pyroptosis,
and ferroptosis, are known to release signals that initiate inflammatory responses.224–229 These
signals include ATP, HMGB1, histones, some amino acid–tRNA synthetases, succinate, and the
IL-1 family members.198,230–234 Finally, the inflammatory response can be induced prospectively
when inflammatory sensors detect stimuli that are anticipated to result in the loss of tissue
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homeostasis.172 These stimuli include microbial agents and foreign bodies.200 Their detection
initiates the inflammatory response even before there is any loss of tissue homeostasis. For
instance, detection of LPS by TLR4 on macrophages leads to an inflammatory response not
because LPS causes disruption of homeostasis, but because it is associated with bacterial
pathogens that do. The inflammatory response to LPS is therefore induced preemptively, in
anticipation of the loss of homeostasis. The sensors involved in initiating preemptive
inflammatory responses are various pattern recognition receptors, typically on innate immune
cells, and the resulting signals are well-known inflammatory mediators, including cytokines and
chemokines.235

In summary, inflammatory responses are induced either as a result or in anticipation of the loss
of tissue homeostasis. In the former case, inflammation is induced either by extreme deviations
of homeostatic variables or by tissue damage that results from the loss of homeostasis. In the
latter case, inflammation is induced when conserved microbial products (pathogen-associated
molecular patterns) or allergens are detected, before tissue damage takes place.172,220 In all cases,
the inflammatory response follows the same general design as the homeostatic circuit, with the
same four universal components (Figure 6.3b). Inflammatory triggers are monitored by a sensor
that produces inflammatory signals that act on various effectors, either locally within the tissue
or systemically. The ultimate goal of the inflammatory response is to restore the system to a
homeostatic state and its regulated variables to their set points.
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Effect of inflammation on core functionalities in tissues
In previous sections, we described how primary and supportive cells within tissues act as the
effectors within homeostatic circuits. Homeostatic and stress signals tune the core functions of
those cell types in order to maintain regulated variables at the appropriate levels, both
systemically and within the tissue environment. Similarly, inflammatory signals increase or
decrease those same core cellular functions in order to achieve their effects. To understand how
inflammation alters the cellular functions within tissues, we can consider the well-studied
example of microbial infection. Sensing of microbes within tissues triggers the production of
inflammatory cytokines and chemokines that cause vasodilation and increase vascular
permeability, allowing for the recruitment of neutrophils into the tissue. At the infection site,
neutrophils become activated and release neutrophil extracellular traps (NETs), proteases, and
other antimicrobial agents to contain the pathogens and prevent them from spreading
systemically.236,237 In the short term, these inflammatory responses alter cellular functions (like
endothelial permeability) and tissue composition (like neutrophil recruitment) in the service of
inflammation. However, in the long term, this is necessary to prevent more severe damage by the
spread of microbes and ultimately to restore tissue homeostasis.

To achieve these ends, the inflammatory response follows three important principles: First,
inflammatory signals alter tissues by making quantitative changes to the performance of their
core functionalities. Second, inflammatory functions take priority over homeostatic functions:
The inflammatory signals must override incompatible homeostatic signals to change the
performance of cells’ core functions. Third, similar to the hierarchy that exists in tissue-level and
systemic homeostasis, changes in the core functionalities of supportive cell types enable
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inflammation at the tissue level while changes in the core functionalities of primary cell types
support inflammation at the systemic level. In this section, we discuss each of these
generalizations and their implications.

Most commonly, inflammatory signals act directly on a given cell type to enhance or suppress
certain core functions that it performs (Figure 6.3c). For example, core functions of fibroblasts
are production of ECM and production of growth factors. These functions can be modulated by
inflammatory cytokines such as TNF and IL-13.238,239 The core functions of adipocytes are lipid
uptake from circulation for storage and lipid release when there is a demand for fatty acids in
other organs. Inflammatory cytokines (TNF, IL-1, and IL-6) suppress lipid storage by inhibiting
lipoprotein lipase and at the same time promote lipolysis to increase fatty acid release.240 A core
function of endothelial cells is to form an internal barrier to separate the tissue environment from
the systemic environment while allowing selective exchange of oxygen and metabolites.241 They
are often the first target of inflammatory signals and provide a good example of how these
signals change core functionalities. Endothelial barrier function is modified to either increase or
decrease endothelial permeability. Histamines released from mast cells during allergic
inflammation or prostaglandins produced during microbial infections can activate specific G
protein–coupled receptors (GPCRs) on endothelial cells, leading to an increase in intracellular
calcium and activation of Rho signaling through the Gαq subunit.242–244 Elevated calcium
activates myosin light chain (MLC) kinase, and Rho signaling inhibits the MLC phosphatase.
Synergistically, these two signaling pathways increase phosphorylated MLC, which initiates
actin filament contraction to increase permeability.245 In contrast, activation of GPCRs through
the Gαs subunit increases cyclic AMP synthesis, which strengthens tight junctions, reduces
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actomyosin contraction, and decreases barrier permeability.246,247 Ligands such as adenosine,
when signaling through adenosine A2 receptors, activate Gαs proteins to change endothelial
permeability in the opposite direction of inflammatory signals.248 These GPCR-mediated
inflammatory and anti-inflammatory effects take place within minutes of stimulation.249 In
addition to GPCR signaling, cytokines such as TNF and IL-1β activate downstream transcription
factors NF-κb and AP-1 in endothelial cells and drive vascular permeability and leukocyte
adhesiveness in a manner that is dependent on new protein synthesis.244–250 This process takes a
few hours and thus follows GPCR activation to regulate permeability on a longer timescale.
Although different types of inflammation elicit different inflammatory mediators, these signals
generally converge to dial up or down the core functions of particular cell types.

To enable inflammatory responses within tissues, inflammatory signals must act on multiple cell
types and change their core functionalities in a coordinated fashion. For example, the core
function of vascular smooth muscle is to control blood flow through contraction and relaxation,
and the core functions of vascular endothelial cells include barrier and transport functions.
During inflammation, cytokines, prostaglandins, and nitric oxide promote relaxation of vascular
smooth muscle, causing increased blood flow to the site of inflammation.251,252 This is coupled
with the activation of endothelial cells, which secrete chemokines, increase surface expression of
adhesion molecules (ICAM-1, VCAM-1, E-selectin, P-selectin) for circulating neutrophils, and
increase barrier permeability for fluids rich in plasma proteins.244 Extensive signaling between
endothelial and smooth muscle cells ensures coordinated actions to recruit immune cells from
circulation into the tissues (an extension of the transport function of the endothelium).
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In the examples cited above, the inflammatory signals change the core functions by acting
directly on the cell types that perform these functions. However, in some cases, the effects of
inflammatory signals can be indirect, through processes that contribute to or control the core
functions (Figure 6.3d). These indirect effects are often mediated through control of
differentiation of cells performing a given function, particularly when these cell types are shortlived. For example, IL-13 indirectly promotes epithelial barrier function by stimulating
differentiation of goblet cells, which in turn secrete mucus to reinforce the epithelial barrier.253
Similarly, TNF and granulocyte colony-stimulating factor (G-CSF) produced during bacterial or
fungal infection act on hematopoietic progenitors to increase neutrophil differentiation, while IL5 produced during helminth infection promotes generation and migration of eosinophils.254,255
This theme applies not only to inflammatory signals but also to the homeostatic signals discussed
above, which can have their effects on core functions either directly or indirectly (Figure 6.3d).
EPO acts indirectly, for example, because it increases the differentiation of red blood cells to
increase oxygen-carrying capacity, rather than directly enhancing their oxygen-carrying
function.256 Finally, inflammatory signals can also modulate core functionalities through their
effects on homeostatic signals (Figure 6.3c,d).

This leads us to the second generalization, which is that inflammatory signals take precedence
over homeostatic signals, in order to coordinate emergency functions. This can occur in a few
ways. Inflammatory signals can act on the same effector that participates in the homeostatic
circuit, overriding the effect of the homeostatic signal and changing the quantitative performance
of the effector’s core functionalities. Alternatively, inflammatory signals can act on the
homeostatic sensor, changing its ‘gain’ (input-output function) (Figure 6.3b-d). To illustrate
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this, consider the bone, the primary function of which is to provide mechanical support for the
organism. To perform this function, osteoblasts (primary cells) and osteoclasts (supportive cells)
work as a complementary unit. The core function of osteoblasts is to deposit ECM, and the core
function of osteoclasts is to degrade or resorb ECM. (These are essentially specialized fibroblasts
and macrophages, respectively, which also regulate ECM in their roles as supportive cells in
other tissues.) Homeostatic control of this system operates through the production of growth
factors for each cell type (Table 6.2). The main growth factors for osteoclasts are macrophage
colony-stimulating factor (MCSF) and receptor activator of NF-κB ligand (RANKL), both of
which are produced by osteoblasts. Under normal conditions, therefore, osteoblasts regulate the
numbers of the supportive osteoclasts to maintain control of bone homeostasis.257 Inflammatory
signals like TNF, however, override this homeostatic circuit in one of two ways: (a) They act
directly on osteoclasts to promote osteoclast differentiation and activity or (b) they act on
osteoblasts to increase the level of RANKL, which in turn controls osteoclast numbers.
Similarly, the cytokine IL-4 can oppose the activity of TNF by preventing both its direct effects
on osteoclasts and its effect on osteoblast expression of RANKL.258,259
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Figure 6.3. Regulation of core functionalities by homeostatic and inflammatory signals
(A) The value of a regulated variable (RV) varies as a function of time, but homeostatic mechanisms
maintain it within a homeostatic range around a set point. When the RV experiences more significant
deviations within the homeostatic range, the stress response acts to restore the RV to the set point. When
the RV deviates beyond the homeostatic range, this extreme deviation triggers an inflammatory response
to return the RV to the homeostatic range. (B) The inflammatory circuit has a parallel structure to that of
the homeostatic circuit, consisting of an inflammatory trigger, sensor, signal, and effector. The effectors of
inflammatory responses eliminate inflammatory triggers (e.g. bacteria) or resolve the tissue disruption
caused by the inflammatory triggers. In addition to regulating effector functions specific to inflammation,
inflammatory signals also act on sensors and effectors of homeostatic circuits to control homeostatic
effector functions. (C) Homeostatic signals and inflammatory signals can directly control the core
functionalities of cells. Inflammatory signals can also operate by changing the levels of homeostatic
signals (dashed arrow). These signals quantitatively increase or decrease the core functions and can
operate in the same or opposite directions. For example, epinephrine decreases bronchial smooth muscle
contraction (or causes relaxation) by acting on β-adrenergic receptors. During allergic responses,
histamine released by mast cells and basophils increases smooth muscle contraction, antagonizing
homeostatic control to cause bronchial constriction. (D) Homeostatic signals and inflammatory signals can
act indirectly by regulating a cellular process, such as cell differentiation or migration, that in turn controls
the core function of cells. For example, Notch signals inhibit goblet cell differentiation, which limits the
quantity of mucus secretion by goblet cells during homeostasis. Parasitic infection increases IL-13
production, which increases goblet cell differentiation and enhances mucus production. Abbreviations:
HS, homeostatic signal; IS, inflammatory signal; RV, regulated variable.
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RANKL 269
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↑ IL-6 275
IL-6 206

↓ IL-22 278,279

↑ acetylcholine 280
↑ IL-13 253
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↓ Notch
↑ acetylcholine,

serotonina,
histaminea 165,221

Self-renewal ↑ Wnt,282 PG,283
and
IL-7, EPO,256 Mdifferentiation CSF, GM-CSF 284
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↑ serotonina,
histaminea 221

↑ TNF, IL-1β, IL-6
(neutrophils,
monocytes),254 IL-5
(eosinophils),255
TSLP (basophils)285

Table
6.2.

Effects of homeostatic and inflammatory signals on core functionalities of cell types within
tissues
Abbreviations: BMP, bone morphogenetic protein; FGF, fibroblast growth factor; GM-CSF, granulocytemacrophage colony-stimulating factor; IGF-1, insulin-like growth factor 1; M-CSF, macrophage colonystimulating factor; NO, nitric oxide; OPG, osteoprotegrin; PG, prostaglandin; RANKL, receptor activator of
NF-κB ligand; TNF, tumor necrosis factor; TSLP, thymic stromal lymphopoietin.
aThese signals can be both homeostatic and inflammatory. In these contexts, the quantity of the signal
determines whether it has homeostatic or inflammatory functions.
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Most of the examples that we discuss above describe changes in supportive functions that control
tissue-level biology during inflammation. However, recall that, under homeostatic conditions,
primary cell types within tissues perform supportive functions at the organismal level to maintain
regulated variables of the entire organism. Similarly, in the context of inflammation, we can
make the final generalization that changing core functionalities of primary cells supports
inflammatory responses at the organismal level (Figure 6.4). In the case of systemic infections,
for instance, adjustments in the primary function of different organs are coordinated to enable
systemic inflammatory responses against pathogens and promote tissue-level tolerance to those
responses.286,287 In systemic inflammation, cytokines TNF, IL-1, and IL-6 act on many primary
cell types to tune their core functionalities. For example, as noted earlier, these cytokines act on
adipocytes to suppress lipid uptake from the circulation and promote lipolysis,206,276,277 on
skeletal muscle cells to release amino acids,288 and on hepatocytes in the liver to optimize the
production of ketone bodies.289 These signals also act on pancreatic beta cells to inhibit insulin
production and on hepatocytes, skeletal muscle cells, and adipocytes to reduce responsiveness to
insulin.290,291 They dramatically increase the secretory function of hepatocytes, inducing
secretion of large quantities of acute phase proteins into circulation, which in turn further
propagate the inflammatory response.292 In addition, they change the activity of hypothalamic
neurons to induce fever and anorexia.293,294 These changes both support the metabolic demands
of the immune response and render the host more tolerant to the damage caused by
inflammation.286,295–297 The primary functions of different tissues are thus adjusted and
coordinated by systemic inflammatory signals to optimize the systemic inflammatory response.
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Tissue A

Tissue B

ES

S

S

IS

THV

S

SHV

E

IS

THV
E

E

IS
THV - Tissue homeostatic variable
SHV - Systemic homeostatic variable
S, E - Sensors and Effectors
PS - Paracrine signal
ES - Endocrine signal
IS - Inflammatory signal

Primary Cell
Supportive Cell

Figure 6.4. Local and systemic effects of inflammatory signals
At the tissue level, supportive cell types act as inflammatory sensors and effectors. Inflammatory signals
act on effectors to change tissue homeostatic variables, such as cell composition and endothelial
permeability. These changes are often required to facilitate inflammatory responses at the tissue level. At
the systemic level, inflammatory signals act on primary cell types to change systemic homeostatic
variables and coordinate the systemic inflammatory response. Abbreviations: E, effector; ES, endocrine
signal; IS, inflammatory signal; S, sensor; SHV, systemic homeostatic variable; THV, tissue homeostatic
variable.
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Inflammatory diseases
The goal of the inflammatory response is ultimately to restore homeostasis. This is obvious in the
case of infection-induced inflammation, where a successful inflammatory response results in
elimination of the pathogen. However, in the process of achieving that goal, the inflammatory
response leads to temporary disruption of homeostasis. This occurs in part because collateral
tissue damage is an unavoidable consequence of antimicrobial immune responses, but also
because inflammation deliberately alters many aspects of tissue homeostasis. Recruitment of
monocytes and granulocytes changes cell numbers and composition within tissue compartments,
and the inflammatory exudate changes the interstitial fluid volume and protein concentration.200
Proteases produced by neutrophils degrade ECM proteins, and the functions of most cell types
within an inflamed tissue are altered by inflammatory cytokines.237 Similarly, inflammation
alters many aspects of systemic homeostasis, such as body temperature, metabolism, and
endocrine functions.286 These changes, which are clearly a departure from a homeostatic state,
are necessary to eliminate the inflammatory trigger (such as a pathogen) and ultimately restore
homeostasis.

As described in the previous section, a general theme of inflammation is that inflammatory
signals override homeostatic pathways that are incompatible with inflammatory processes. For
example, maintaining stable cell composition within the tissue compartment is clearly
incompatible with recruitment of inflammatory cells necessary to combat an infection.298
Therefore, the mechanisms that maintain cell numbers within tissues have to be overridden by
inflammatory signals to allow for neutrophil and monocyte recruitment. Inflammation has higher
biological priority than many homeostatic functions because the benefits of the inflammatory
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response generally outweigh the costs of temporary loss of homeostasis. This very property of
inflammatory signals, however, also creates a vulnerability: Homeostasis can be persistently
overridden and disrupted by dysregulated or chronic inflammation, leading to disease. To
illustrate this, we can examine how the inflammatory signals that regulate core functions in bone
can also drive clinical pathology. In rheumatoid arthritis, which is characterized by erosion of
bone tissue within joints, sustained type 1 inflammation (including TNF, IL-1, and IL-6) drives
increased RANKL expression in osteoblasts, which in turn causes increased osteoclast
activity.259 Another set of chronic inflammatory disorders known as spondyloarthropathies (such
as ankylosing spondylitis and psoriatic arthritis) are characterized by the opposite process—new
bone formation at specific anatomical sites. These diseases are driven by a distinct set of
cytokines that have the opposite effect on core cellular functions: IL-23 (together with IL-22 and
IL-17) acts to increase osteoblast deposition of ECM, again both directly and by increasing
levels of normal, homeostatic growth factors.259,267 The same principle applies to type 2 (allergic)
inflammation. For instance, patients with chronic asthma often have prominent infiltrates of type
2 inflammatory cells in the airways, such as eosinophils, mast cells, basophils, type 2 T helper
cells, and group 2 innate lymphoid cells.299 These cells produce type 2 cytokines, like IL-13,
which are responsible for changing the core functions of local cell types, including increasing
goblet cell differentiation and mucus production, fibroblast ECM deposition, and bronchial
smooth muscle contractility. These changes, when they are persistent, lead to pathologic airway
remodeling in asthma.299,300 Sepsis is a common and often fatal example of sustained
inflammatory signaling. One of the hallmarks and dangers of sepsis is hypotension. As described
above, inflammatory cytokines (like TNF, IL-1, and IFN-γ) and prostaglandins induce relaxation
of vascular smooth muscle, both directly and through induction of nitric oxide production by
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macrophages and smooth muscle itself.251,265,301 This inflammatory regulation of smooth muscle
function is typically adaptive, allowing for increased blood flow to the site of inflammation. But,
because these signals override normal homeostatic regulation, it makes the system susceptible to
disease and even death in the case of sustained inflammatory signaling, which can cause
systemic hypotension and decreased blood flow to vital organs.301

Concluding remarks
Here we present a perspective on tissue homeostasis and inflammation based on a framework for
understanding the functional organization of tissues. We describe how the core functions of
supportive and primary cell types are assembled into tissues that are optimized to perform
particular functions for the organism, how these core functionalities are tuned up and down to
maintain tissue and organismal homeostasis, and how inflammation overrides homeostatic
control to coordinate emergency functions and ultimately defend homeostasis.

Homeostasis is a powerful concept that, if carefully defined, can be applied for understanding
tissue biology and inflammation. The homeostatic and inflammatory circuits are composed of the
same components, including sensors, which monitor variables of interest, and effectors, which
can change the values of these variables in the desired direction. Inflammation is induced by one
of three possible indicators of the loss of homeostasis. First, inflammation can be induced by
extreme deviations of regulated variables, beyond their normal range—a direct indication of the
loss of homeostasis. This form of inflammation relates to what Metchnikoff called physiological
inflammation and, if the inflammatory response is successful, likely does not manifest in clinical
symptoms. Second, inflammation can be induced retrospectively by the consequences of the loss
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of homeostasis, such as nonapoptotic cell death or the disruption of tissue architecture. This type
of inflammation may fall into Metchnikoff’s pathological inflammation category (where
pathological refers to the cause rather than the consequence). Finally, inflammation can be
induced prospectively, when inflammatory sensors detect pathogens or allergens, as indicators of
forthcoming loss of homeostasis. The ensuing inflammatory response would match what
Metchnikoff referred to as immunity—the highest end of the inflammatory spectrum. While we
can now appreciate that Metchnikoff had a deep intuition about the homeostasis-inflammation
spectrum, more work will be required to fully elucidate its underlying principles and
mechanisms.
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Chapter 7: Materials and Methods

Cell culture
All cells were cultured at 37˚ Celsius (C), 5% carbon dioxide (CO2), and atmospheric oxygen.
Experimental techniques were performed in BSL2 biosafety cabinets under sterile conditions.
Cells were monitored by microscopy using a Zeiss Axio Vert.A1 microscope, which was also
used to photograph live cells to document cell morphology. Photographs were saved as .tiff files.

Bone marrow derived macrophages
Bone marrow derived macrophages (BMDM) were differentiated from mouse bone marrow cells
for at least 7 days in MCSF-rich macrophage growth media (MGM) composed of 30% L929-cell
conditioned media and 70% complete RPMI media (cRPMI), which consisted of RPMI-1640
(Corning) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco), 2 mM Lglutamine, 200 U/mL penicillin/streptomycin, 1 mM sodium pyruvate, and 10 mM HEPES.
Bone marrow was prepared by crushing mouse femurs and tibias to release marrow, followed by
ACK (ammonium-chloride-potassium) lysis of red blood cells and passage through a 70-µm cell
strainer. Bone marrow was plated on day of isolation (day 0) at 5 × 106 cells in 20 mL of MGM
in a 15-cm petri, or non-tissue culture (non-TC), dish. Every three days, cells were supplemented
with 10 mL of MGM until they reached confluence. After day 6, adherent cells were lifted with
cold phosphate-buffered saline (PBS) containing 5 mM EDTA. Cells were then centrifuged at
1350 rpm at room temperature for 5 minutes, resuspended in 3 mL cRPMI, counted at a 1:1 ratio
with Trypan blue, and then diluted to the appropriate concentration (or centrifuged again and
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resuspended at the appropriate concentration) in cRPMI and used for experiments. Experiments
on tissue culture (TC) or non-TC dishes were typically performed at 0.33 × 106 cells per well of
a 12-well dish. Experiments in collagen gels or on polyacrylamide gels are described below.

Murine embryonic fibroblasts
Murine embryonic fibroblasts (MEFs) were harvested from male and female E13.5-E14.5
embryos and sorted for purity. Embryos were removed from a pregnant female by removing the
uterus and separating each embryo from its amniotic sac. The head and ‘‘red tissue,’’ including
fetal liver, were removed and discarded. The remaining portion of each embryo was minced
using razor blades in 0.05% trypsin + EDTA and placed in a 37˚C incubator for 30 minutes.
After digestion, the tissue was transferred into a conical tube, washed with complete DMEM
(DMEM + 10% FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES, 200 U/mL
penicillin/streptomycin) and resuspended in complete DMEM in 15 cm tissue culture plates
overnight. The following day, cells and undigested tissue debris were lifted from the plates using
0.05% trypsin + EDTA, spun down, resuspended, and filtered over a 70-µm cell strainer. These
cells were expanded for 1-2 passages and then sorted for CD45-, CD11b-, and F4/80-negativity
to exclude contaminating macrophages. The sorted MEFs were split once after sorting to allow
for recovery and used for experiments between passage 3 and passage 7.

Materials
Recombinant murine IL-4 (Peprotech, 214-14) was used at 20 ng/mL, and recombinant murine
MCSF (Cell Signaling Technologies, 5228) at 100 ng/mL, for stimulation of BMDM unless
otherwise specified. Chemical inhibitors used in cell culture included latrunculin A (Cayman
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10010630, Sigma 428021), (-)-blebbistatin (Sigma B0560), nocodazole (Sigma M1404),
wortmannin (Millipore 681675), and SB216763 (Cayman 10010246).

For antibody blockade of cell-surface receptors, cells were pre-incubated in a small volume of
media with 160 ug/mL of antibody for 15 minutes at room temperature, followed by dilution to a
final concentration of 20 ug/mL for the duration of the experiment. b1 integrin blockade was
performed with Purified NA/LE Hamster Anti-Rat CD29 (Clone Ha2/5, BD Pharmingen,
555002) and the isotype control antibody Purified NA/LE Hamster IgM, λ1 Isotype Control
(Clone G235-1, BD Pharmingen, 553957). b2 integrin blockade was performed with Purified
NA/LE Rat Anti-Mouse CD18 (Clone GAME-46, BD Pharmingen, 555280).

Talin-flox (mice originally produced by Dr. David Critchley) and Talin-flox LysMCre bone
marrow were generously provided by the laboratory of Dr. Gwendalyn Randolph (with the help
of Dr. Nan Zhang), with permission of the University of Leicester, Oklahoma Medical Research
Foundation, and Washington University-St. Louis, as specified in a Material Transfer
Agreement.

Three-dimensional collagen gels
Preparation of 3D collagen gels with embedded cells for cell culture
Three-dimensional collagen gels with embedded BMDM or MEFs were synthesized using highconcentration rat tail collagen I (Corning, 354249), using a protocol adapted from Corning’s
“alternate gelation procedure” provided with the product.302 A detailed protocol is provided in
Appendix 1. Excel spreadsheets to facilitate calculations of reagent quantities and cell numbers
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could not be embedded but are available upon request to matt.meizlish@gmail.com, and the
approach is summarized here.

Briefly, collagen is obtained from Corning in a 0.02 N acetic acid solution and remains in a
liquid state when kept cold and at an acidic pH. Until gelation is desired, collagen solution
should be kept on ice as much as possible. Collagen is mixed with 10x PBS and sterile H2O to
achieve the desired collagen concentration. 1 N NaOH is added to neutralize the acetic acid in
the collagen solution, titrating up and checking the pH (after gently vortexing the collagen
solution to mix it) by pipetting 10 uL of solution onto a pH strip until a pH of 7-7.5 is achieved.
For subsequent experiments, NaOH volume is conservatively estimated based on previous
experiments, scaling up or down according to the volume of collagen being used (because this is
the source of acid) and again checking with pH strips. After the collagen solution is at a neutral
pH, cells are added such that they make up 1/8 of the volume of the gel and are mixed into the
collagen solution with a pipette (not vortexed). Gels were typically plated at 200 uL in 48-well
non-TC plates. BMDM were added to the collagen solution at 20-40 million cells/mL, for a total
of 0.5-1 million cells per gel. MEFs were typically added to the collagen solution at 8 million
cells/mL, for a total of 0.2 million cells per gel. Notably, the high-concentration collagen
solution is viscous, and there is some loss of volume during this process, so excess collagen
solution must be made to have enough for plating. Typically, scaling up by a factor of 1.6 for
high-collagen gels and 1.3 for low-collagen gels is appropriate. When multiple genotypes or
other conditions (such as antibody blockade) required splitting the collagen solution into two
batches prior to adding cells, a master stock was made for each collagen concentration and then
split into batches. An additional scaling factor of 1.3-1.4 is required for the loss that occurs
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during this splitting, but it ensures that the batches are cultured in equivalent gel conditions.
After collagen-cell solutions are plated, they are incubated for 45 minutes to 1.5 hours at 37˚C
and 5% CO2 to achieve gelation. A small pipette tip is used to score around the edge of the gels
to detach them from the walls of the wells and ensure that they float (to avoid cells interacting
with the stiff bottom of the plate). Media (400 or 500 uL) is then added with any stimulation or
inhibitors, and the gels are scored once again before placing them back in the incubator for the
duration of the experiment.

Harvesting RNA for qPCR from cells in 3D collagen gels
Collagen gels were removed from the cell culture incubator 16-28 hours after stimulation and
brought to a chemical fume hood. Gels were transferred with curved, blunt, serrated forceps to a
pre-labeled 24-well non-TC plate, rinsing forceps between each gel. RNA-Bee (Tel-Test, CS501B) 1 mL was then added to each gel and allowed to sit for approximately 5 minutes or until
gels began to fragment. RNA-Bee and gel were then pipetted up and down with a P1000
repeatedly until the gel disintegrated and the solution was homogenous. This solution was then
transferred to labeled 1.5 mL Eppendorf tubes on ice. When all samples were collected,
Eppendorf tubes were stored at -80˚C until RNA isolation.

Harvesting protein for Western blot from cells in 3D collagen gels
2x SDS-PAGE sample buffer with b-mercaptoethanol and protease/phosphatase inhibitor was
pre-heated at approximately 105˚C for approximately 10 minutes, in labeled Eppendorf tubes
containing 200 uL of sample buffer. Gels (200 uL each) were then transferred to prewarmed 2x
sample buffer using a curved, blunt, serrated forceps (effectively diluting the sample buffer to
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1x). Samples were then heated at 105˚C for 15 minutes, visualized to ensure homogenization,
and transferred to -80˚C for storage until continuing with the Western blot procedure.

Harvesting cells from 3D collagen gels for flow cytometry
Collagenase Type IV (Worthington, LS004189) was added at 18 mg/mL, 100 uL per well, to 500
uL media in which cells were cultured, for a final concentration of 3 mg/mL. Gels were diced
with clean scissors directly in the wells. Plates were taped in an orbital incubator shaker
(Barnstead MaxQ4000) and rotated at 205 rpm for 20 minutes. Samples were then transferred
(with partially homogenized gels) to labeled 50 mL conical tubes (kept on ice) through a cell
strainer, using the top of a plunger to push the contents through the strainer, followed by 2
washes with PBS (using the plunger in between). Samples were then centrifuged in a large tabletop centrifuge at 1350 rpm (385 x g) at 4˚C for 5 minutes and resuspended in 150 uL cold PBS
before being transferred to a FACS plate for staining.

Measurement of collagen gel diameter
Collagen gel diameter was measured by holding a ruler against the bottom of the cell culture
plate and measuring the diameter at the widest portion of the gel. Photographs were also obtained
using an iPhone camera.

Confocal microscopy of cells in 3D collagen gels
In preparation for confocal microscopy, gels were prepared in chambers with coverglass wellbottoms (Lab-Tek Chambered #1.0 Borosilicate Coverglass System, 8-chamber, #155411).
Collagen gels were 200 uL per well as usual but were not scored (they should sit on the bottom
139

of the well to be as close as possible to the microscope objective), and 300 uL of media was
added after gelation. At the end of the experiment, media was removed with a pipette, gels were
washed gently with PBS, and gels were fixed in 300 uL 4% paraformaldehyde (PFA) for 1 hour
at room temperature on a bench-top rotator (secured with tape). Gels were washed three times
with 400 uL PBS and then permeabilized with 0.5% Triton X-100 for 1 hour at room
temperature on the rotator. Gels were washed three times with PBS and incubated with
Phalloidin-Texas Red (ThermoFisher Scientific, T7471) at 1:100 in PBS/5%BSA (or 5% donkey
serum) for 1 hour in the dark at room temperature on the rotator. Gels were then counterstained
with DAPI 1:10,000-1:40,000 for 5 minutes. Gels were washed three more times with PBS, this
time rotating for 5 minutes in the dark during each wash. Gels were kept in PBS and imaged by
confocal microscopy, scanning for cells above the bottom of the gel and obtaining Z stacks to
capture several whole cells in each image, which were then used for downstream analyses.
Cellular morphology was quantified in Imaris Software (Oxford Instruments) for each cell whose
borders were fully captured in the acquired confocal images. “Surfaces” were created
automatically for cells using the default setting of 0.359 um for Surfaces Detail (to avoid bias)
and were then filtered manually to include only genuine cells. The software was then used to
calculate the morphology of surfaces, including cell sphericity.

Polyacrylamide-fibronectin gels
Polyacrylamide gel fabrication
Hydrogels were generated by polymerizing various ratios of solutions of acrylamide (Bio-Rad,
3% and 10% for low- and high-stiffness, respectively) and bis-acrylamide (Bio-Rad, 0.3% and
0.225% for low- and high-stiffness, respectively) with ammonium persulfate (Sigma) and
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tetramethylethylenediamine (Bio-Rad) sandwiched between two glass coverslips. One coverslip
was activated with 3-aminopropyltriethoxysilane using 0.1 M NaOH (Macron Fine Chemicals)
and 0.05% glutaraldehyde (Polysciences Inc.) and the other coated with dichloromethylsilane
(Sigma). Fibronectin was conjugated to the polymerized hydrogels by succinimide chemistry.
Briefly, 0.2 mg/mL Sulfa-SANPAH (ThermoFisher Scientific) in 50 mM HEPES (Sigma) were
placed under UV (365 nm, 10 mW/cm), washed thoroughly with HEPES, and incubated
overnight with 0.2 mg/mL fibronectin (Millipore) at 37ºC. After incubation, the hydrogels were
washed and kept at 4ºC until cell seeding.

Cell culture on Polyacrylamide-fibronectin gels
Gels (attached to coverslips) were transferred to 6-well non-TC plates using sterile, curved,
pointed forceps. BMDM (0.85 million cells per gel in 250 uL cRPMI) were gently plated at the
center of each gel such that the media formed a meniscus and did not spread beyond the border
of the gel. Cells were left to incubate undisturbed for 30 minutes to 1 hour, after which adhesion
was confirmed by microscopy. An additional 1.75 mL cRPMI was then added to each gel by
gently pipetting 0.875 mL along the back wall of the well and 0.875 mL along the front wall of
the well, such that the new media merged with the media on the gel, without disrupting the cells.
Cell culture plates were then returned to the incubator for 3 hours, after which photographs of
cells were obtained and stimulation with IL-4 (20 ng/mL) was performed. Cells were returned to
the incubator for an additional 16 hours.

RNA isolation from Polyacrylamide-fibronectin gels
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Gels were transferred to new 6-well non-TC plates in the cell culture hood, taking care to cause
minimal mechanical disruption. RNeasy RLT buffer (QIAGEN) with 1:100 b-mercaptoethanol
was added to the center of the gel at 350 uL per gel. Plates were allowed to sit for several
minutes and then brought to the laboratory bench, where RLT buffer on each gel was gently
pipetted up and down and then transferred to Eppendorf tubes. The plate was then tipped forward
to collect the remainder of the RLT buffer, which was transferred to the same Eppendorf tubes.
Samples were then stored at -80˚C until RNA isolation, which was performed with the RNeasy
Micro Kit (QIAGEN, 74004) according to manufacturer instructions.

Immunofluorescence imaging on Polyacrylamide-fibronectin gels
For immunofluorescence (IF) experiments, BMDM were plated at a lower cell density (0.4
million cells per gel) in 250 uL cRPMI. Cells were allowed to adhere for 2 hours (without
addition of more media), after which gels were transferred to new wells, washed once with 400
uL PBS, and fixed with 400 uL 4% PFA for 10 minutes at room temperature. Gels were then
washed three times with ice cold PBS and permeabilized with 0.1% Triton X-100 in PBS for 10
minutes at room temperature. Gels were again washed three times with PBS and then stained
with 400 uL Phalloidin-Texas Red (ThermoFisher Scientific, T7471) at 1:100 in PBS/1% BSA
for 1 hour in the dark. DAPI solution was added for the last 10 minutes of staining in 100 uL at
1:2,000 for a final concentration of 1:10,000. Gels were washed three times with PBS
(incubating for a few minutes in the dark with each wash). A dot of Prolong Diamond Antifade
Mountant (ThermoFisher Scientific, P36961) was then placed in the center of the gel, and a
coverslip of the same size as that to which the gel was attached (Fisher Microscopic Cover Glass,
12-546-2, 25CIR-2) was placed on top of the gel to spread the mounting media. The mounting
142

media was allowed to cure in the dark overnight, and nail polish was then used to seal the edges
of the coverslips. Cells were imaged at 20x magnification on a Leica DMI6000 B microscope.

RNA isolation, cDNA synthesis, and quantitative PCR
After cell collection in RNA-Bee, RNA was isolated by chloroform extraction and isopropanol
precipitation, except when isolating RNA from PA gels, as indicated, or in preparation for
RNAseq experiments, for which the aqueous phase after chloroform extraction was mixed 1:1
with 70% ethanol and further processed with QIAGEN RNeasy Mini columns (74106), with oncolumn DNAse treatment, according to manufacturer instructions. To synthesize, cDNA, RNA
was annealed to oligo-dT6 primers, and cDNA was reverse-transcribed with MMLV reverse
transcriptase (Clontech). Quantitative reverse-transcriptase polymerase chain reaction (qPCR)
was performed on a CFX96 or CFX384 Real-Time System (Bio-Rad) using PerfeCTa SYBR
Green SuperMix (Quanta Biosciences). Relative expression units were typically calculated as
transcript levels of target genes relative to Rpl13a *1000. Primers used for qPCR are listed in
Appendix 2.

Live cell imaging
Image acquisition began shortly after the addition of media to collagen gels and was performed
using a Leica AF6000 Modular System with stage-top incubator INUBTFP-WSKM-F1 (Tokai
Hit) maintained at 37 ˚C and 5% CO2. Multiple images were acquired from each sample every
3-5 minutes for 16-20 hours, and videos were assembled from serial images at a single position.
Imaris Software (Oxford Instruments) was used to track individual cells throughout the video, in
order to quantify the mean track speed and track displacement of each cell.
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Flow cytometry
BMDM were collected for flow cytometry from collagen gels as described above or from nonTC dishes with cold PBS with 5 mM EDTA. All staining steps and washes were performed in
FACS buffer (PBS with 2% FBS, 0.01% sodium azide) unless otherwise indicated. Cells were Fc
blocked with anti-CD16/CD32 (clone 93, eBioscience) at 1:500 and stained with Zombie Yellow
at 1:200 for 10 minutes at room temperature in the dark. Cells were washed twice with FACS
buffer and then fixed and permeabilized with BD Cytofix/Cytoperm buffer (51-2090KZ) for 1520 minutes. Cells were then washed twice with BD Perm/Wash buffer (554723), and
intracellular staining was performed in BD Perm/Wash buffer for 45 minutes at room
temperature or at 4˚C overnight. Antibodies included anti–RELMα–PE at 1:200 (clone
DS8Relm, eBioscience, catalog no. 12-5441-80), anti–Arginase1-APC at 1:200 (clone AlexF5,
eBioscience, catalog no. 17-3697-82), and anti-Cleaved Caspase-3 (Asp175) at 1:400 (Cell
Signaling Technologies, catalog no. 9661). After intracellular staining, cells were washed twice
with BD Perm/Wash buffer and then incubated with secondary antibodies, including Goat antirabbit Alexa Fluor 488 at 1:400 (Invitrogen A11034). Cells were washed twice more with BD
Perm/Wash buffer and filtered into FACS tubes. Samples were run on a BD LSR II Green,
followed by analysis with FlowJo software. Histograms were used to determine the percentages
of cells expressing a given protein.

Western blot
Samples were run on Bio-Rad Mini-PROTEAN TGX Stain-Free Gels, 4-15%, typically with a
10- or 12-well comb (4568085) in Tris/Glycine/SDS buffer. Protein was transferred onto
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activated PVDF membranes using the Bio-Rad Trans-Blot Turbo system according to
manufacturer instructions. Membranes were blocked with TBST (20 mM Tris, 150 mM NaCl,
0.05% Tween 20)/5% BSA for 1 hour and then incubated with primary antibodies in TBST/5%
BSA with sodium azide at 4˚C overnight. Primary antibodies included rabbit anti-phosphoSTAT6 at 1:1000 (Cell Signaling Technologies, 56554), rabbit anti-STAT6 at 1:1000 (Cell
Signaling Technologies, 9326), rabbit anti-RELMa (Peprotech, 500-P214) at 1:1000, and mouse
anti-GAPDH (Santa Cruz, sc-32233) at 1:2000. Membranes were washed three times with
TBST, then incubated with secondary antibodies (anti-rabbit or anti-mouse) at 1:10,000 dilution
for one hour at room temperature. Membranes were washed three more times and then developed
using Pierce ECL Western Blotting Substrate (ThermoFisher Scientific, 32209) or SuperSignal
West Pico Chemiluminescent Substrate (ThermoFisher Scientific, 34080). Protein was visualized
using the Bio-Rad Image Lab system, and the optical density of bands was quantified based on
pixel intensity within boxes of consistent size encompassing each band, normalized to the
background intensity of the membrane.

Animals
All use of animals was performed in accordance with institutional regulations after protocol
review and approval by Yale University’s Institutional Animal Care and Use Committee. Bone
marrow was obtained from adult (≥8-week-old) C57BL/6J mice.

Synthesis of recombinant FIZZ1 (RELMa) and supernatant transfer
Expi293 cells were subcultured at 2-3 million cells/mL on day -1 in Expi293 medium, shaking at
8% CO2. On day 0, cells were diluted back to 2-3 million cells/mL in 25mL Expi293 media, and
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25ug His-FLAG-RELMa (cloned into a derivative of pD2610-v1 from Atum Bio, kindly
provided by Dr. Aaron Ring’s lab) was transfected with ExpiFectamine as per manufacturer’s
instructions. On day 1, enhancer 1 and 2 were added, and conditioned media was harvested on
day 4. Cells were spun at 500 x g, and supernatant was collected, spun again at 500 x g, and
collected prior to filtering through a 0.22 um filter to obtain the final FIZZ1-conditioned media,
which was used to stimulate 3T3L1 fibroblast cells.

RNA sequencing and analysis
Sequencing libraries were constructed following Illumina Tru-seq stranded mRNA protocol.
Paired-end sequencing was performed with Next-seq 500 with paired end reads of 38 base
pairs. Illumina fastq files were downloaded from Illumina Basespace and were aligned with
Kallisto v0.46.1 using the “-b 100 and -t 20” options to obtain transcript abundances in
transcripts per million (TPM) and estimated counts.303 The kallisto index used during transcript
quantification was built from the Mus musculus transcriptome GRCm38 downloaded as a fasta
file from Ensembl (ftp://ftp.ensembl.org/pub/release-90/fasta/ mus_musculus/cdna/s).
Transcripts were annotated using the Bioconductor package biomaRt v2.40.5.304 Significant
differences in gene expression between conditions were calculated, with correction for multiple
comparisons, using Sleuth in R v3.5.1.305

ATACseq
ATACseq was performed according to the protocol detailed by Buenrostro and colleagues.306
UCSC Genome Browser (https://genome.ucsc.edu/) was used for data visualization. HOMER
was used to analyze transcription factor motif enrichment (http://homer.ucsd.edu/homer/).
146

Chromatin immunoprecipitation
Approximately 45 million BMDM per condition (15 million cells/plate on 15 cm TC plates)
were crosslinked with 1% paraformaldehyde directly in TC plates for 10 minutes with gentle
shaking at room temperature. The reaction was quenched by adding glycine for a final
concentration of 125 mM for another 5 minutes with shaking at room temperature. The cells
were washed 3 times with cold PBS and scraped with 10 mL of PBS into 50 ml conical tubes
(one per condition). The cells were centrifuged for 5 minutes at 475 x g at 4 ˚C and supernatant
was removed by decanting. Pellets were resuspended in remaining PBS and transferred to
Eppendorf tubes. Samples were centrifuged at 450 x g at 4 ˚C, supernatant was aspirated with
glass pipettes, and pellets were frozen at -80 ˚C. The next day, pellets were thawed on ice,
resuspended in 1 mL nuclear lysis buffer (10 mM EDTA, 50 mM Tris-Cl (pH 8.0), 1% SDS, 1x
protease inhibitors (ThermoFisher Halt)), and incubated at room temperature for 15 minutes with
mechanical disruption after 7 minutes. Samples were transferred to a 1.5 ml Bioruptor Plus TPX
microtube (Diagenode). The nuclear lysate was sonicated for 3 rounds of 10 cycles of 30 seconds
on/30 seconds off on high power (Diagenode Biorupter plus). After sonication the chromatin was
centrifuged for 15 minutes at max speed at 4 ˚C. Chromatin was diluted with Chip dilution
buffer (16.7 mM Tris pH 8.0, 1.1% Triton X-100, 167 mM NaCl, 1.2 mM EDTA, 0.01% SDS,
1x protease inhibitor (ThermoFisher Halt)). The diluted chromatin was split into low binding
tubes (one tube per antibody), antibody was added, and tubes were rotated overnight at 4 ˚C.
Approximately 100ug of chromatin (measured by nano-drop) were used for ChIP with rabbit
polyclonal anti-C/EBPb IgG antibody (Santa Cruz, clone C-19, sc-150x) and IgG control
(Abcam). The next day, protein G Dynabeads (ThermoFisher 10004D) were washed 3 times with
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PBS + 0.5% BSA. A Dynal magnet (Invitrogen) was used for Dynabeads washing and eluting
steps. After washing, 50 uL of Dynabeads in PBS+BSA were added to each overnight tube
containing the chromatin and antibody and rotated at 4 ˚C for 2 hours. IgG samples were placed
on a magnet and 5% was removed for input. Samples were then washed in the following
sequence: 1× with 1 mL of low-salt wash buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20
mM tris-HCl (pH 8.1), and 150 mM NaCl], 1× with 1 ml of high-salt wash buffer [0.1% SDS,
1% Triton X-100, 2 mM EDTA, 20 mM tris-HCl (pH 8.1), and 500 mM NaCl], 1× with LiCl1
wash buffer [0.25 M LiCl, 1% IGEPAL CA-630, 1% deoxycholic acid (sodium salt), 1 mM
EDTA, 10 mM tris (pH 8.1)], and 2× with 1-ml tris-EDTA (TE) (pH 8.0). DNA was eluted by
resuspending the beads with 250 uL of nuclear lysis buffer supplemented with 3 ul of 20 mg/ml
Proteinase K (Roche) and rotating the beads for 10 minutes at room temperature. The samples
were digested and crosslinks reversed by incubating at 55 ˚C for 2 hours and 65 ˚C overnight.
DNA was purified using the Qiagen MinElute PCR Purification Kit, and DNA was eluted in 200
uL EB buffer. Quantitative PCR was performed using the following ChIP
primers: Fizz1 promoter, AGTCTCTTGAACCACACCTCTTC (forward) and
AGCACTTTCAGTACATTTTGGCC (reverse); Arg1 enhancer, TTAGCCCAGCACCCTCAAC
(forward) and GTGAGGCATTGTTCAGACTTCC (reverse).

Rheology
A PA or collagen hydrogel was cast between the rheometer base plate and 25 mm diameter
parallel plate. Gels were swollen overnight and kept hydrated during testing. The shear modulus
of the gel was measured using a strain amplitude sweep of 0.1-10% strain at a constant frequency
rate (1 rad/s). The measured shear modulus remained constant over the specified strain range.
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The elastic modulus was calculated using the shear modulus values, assuming that the gels were
incompressible (Poisson ratio = 0.5).

Scanning Electron Microscopy (SEM)
Samples were fixed after swelling overnight in a 24 well plate. Hydrogels were then snap-frozen
in liquid nitrogen and lyophilized overnight. Freeze-dried samples were sputter coated with
palladium and imaged via SEM (Hitachi SU-70). Images were taken at 10 kV for pore
quantification. The width of individual pores on the surface was analyzed from SEM images
using ImageJ, quantifying the pore size as the distance between fibers in three dimensional
space.307

Statistical analyses
We used unpaired t tests to determine statistical significance between groups (p < 0.05 was
considered significantly different) using Prism. All data points are presented as Mean ± SD,
unless specified. *p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical analyses for
RNAseq data, including principal component analysis, were performed in R and are described in
greater detail above.

Figures
Figures and schematics were generated using Microsoft PowerPoint, Adobe Illustrator, Apple
Keynote, and Biorender (biorender.com).
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Appendix 1: Protocol for culturing BMDM within 3D collagen gels
Gelation approach is adapted from Corning’s “Alternate gelation procedure” that comes with
their Type I collagen
Materials:
On ice:
1.
2.
3.
4.
5.

Corning® Collagen I, High Concentration, Rat Tail (Product Number 354249)
Sterile 10x PBS
Sterile H2O
Sterile 1 N NaOH
14 mL polystyrene round bottom tubes (label these and put them on ice before starting)

Other:
6.
7.
8.
9.

pH strips (EMD Millipore MColorpHast pH 5.0 – 10.0)
48-well Non-TC plates
cRPMI (RPMI-1640 with supplements and 10% FBS)
Bone marrow derived macrophages (BMDM)

Protocol:
1. Calculate quantities of each reagent needed to make your stock of gel. If you have one type
of BMDM, use the spreadsheet “Collagen gel calculations”. If you have two types of
BMDM, use the spreadsheet “Collagen gel calculations – WT vs. KO”.
2. Lift BMDM with PBS/EDTA (at 4˚C or room temp), followed by PBS wash of plate to
retrieve remaining macrophages.
3. Spin down BMDM in 50 mL conical.
4. Aspirate media and resuspend in 5 mL cRPMI.
5. Count BMDM (if you’re doing this with 2 batches of cells, e.g. WT vs. KO, increase
accuracy by using multiple aliquots to count because cell # may affect phenotypes; if you’re
using one batch of cells, exact cell # is less important).
6. Take desired cell number (see calculations) and spin again; resuspend in desired volume for
final concentration e.g. 40 million cells/mL. (Or spin all BMDM and resuspend in
appropriate volume for 40 million cells/mL). Place cells on ice.
7. Make gels in 14 mL polystyrene round bottom tubes, following protocol in “Collagen gel
calculations” (including notes in italics). Remember to keep them on ice as much as possible.
8. After suspending cells in gels, use P1000 to plate 200 uL gel per well. Pipette slowly to avoid
bubbles. First pipette up and down once in your tube to get rid of bubble at the tip. Then
slowly distribute gel to wells, only going to the first stop to push gel out and going back into
tube before lifting plunger again. I do low-collagen first, then high-collagen, so that highcollagen doesn't begin to solidify before I put it in the incubator.
9. Incubate gels for 45 min. (up to 1.5 hours is okay) at 37˚C, 5% CO2.
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10. Score in a circle around edge of gels, 1 time per gel, using a P2 pipette. (Change tips as
appropriate for switching between samples.)
11. Add 400 uL or 500 uL cRPMI, containing all relevant inhibitors and stimulations (e.g. 20
ng/mL IL-4, 100 ng/mL MCSF). Don’t add stimulations after adding media because the gel
changes its mechanical properties and I believe that penetration of proteins from the media
decreases.
12. Score around edge of each gel one more time to ensure that gels are floating and not attached
to the bottom of the plate, which can change the mechanical properties of the environment
that cells are exposed to. (Change tips as appropriate for switching between samples.)
13. Place gels back in incubator, generally for 16-24 hours before harvesting (or other timing
applicable for your experiment).
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Appendix 2: qPCR primers
gene name
Arg1
Mrc1
Fizz1
Rnase2a
Ear2
Ym1
Fn1
Ccl24
Ctgf
Acta2
Col1a1
Talin1
Rpl13a

primer
name
Arg1_F
Arg1_R
Mrc1_F
Mrc1_R
Fizz1_F
Fizz1_R
Rnase2a_F
Rnase2a_R
Ear2_F
Ear2_R
Ym1_F
Ym1_R
Fn1_F
Fn1_R
Ccl24_F
Ccl24_R
Ctgf_F
Ctgf_R
Acta2_F
Acta2_R
Col1a1_F
Col1a1_R
Tln1_F
Tln1_R
Rpl13a.M_F
Rpl13a.M_R

Sequence (5'->3')
CTGGTGTGGTGGCAGAGG
TGGCCAGAGATGCTTCCAAC
AAAGGGACGTTTCGGTGGAC
CACTCCGGTTTTCATGGCAAC
GATGAAGACTACAACTTGTTCC
AGGGATAGTTAGCTGGATTG
TCCACGGGAGCCACAAAG
GAGGCAAGCATTAGGACATGTC
TCCACGGGAGCCACAAAG
GAGGCAAGCATTAGGACAAGTC
CCCTACAATTAGTACTGGCCCAC
CCTCAGTGGCTCCTTCATTCAG
CAACCTCTGCAGACCTACCC
ACTGGATGGGGTGGGAATTG
AGCATCTGTCCCAAGGCAG
TGTATGTGCCTCTGAACCCAC
AGGGCCTCTTCTGCGATTTC
GACCCACCGAAGACACAGG
ATCACCATTGGAAACGAACGC
TAGGTGGTTTCGTGGATGCC
ACGAGATGGCATCCCTGGA
GCCATAGGACATCTGGGAAGC
TCTACCATGGTGTACGACGC
GACAGAAAGAGCCCAAAGTCG
GAAGGAAAAGGCCAAGATGCAC
TGAGGACCTCTGTGAACTTGC
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